	   SnapGene      ctgacaacgatcggaggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgttgggaaccggagctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgcagcaatggcaacaacgttgcgcaaactattaactggcgaactacttactctagcttcccggcaacaattaatagactggatggaggcggataaagttgcaggaccacttctgcgctcggcccttccggctggctggtttattgctgataaatctggagccggtgagcgtgggtctcgcggtatcattgcagcactggggccagatggtaagccctcccgtatcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacagatcgctgagataggtgcctcactgattaagcattggtaactgtcagaccaagtttactcatatatactttagattgatttaaaacttcatttttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgcctttgagtgagctgataccgctcgccgcagccgaacgaccgagcgcagcgagtcagtgagcgaggaagcggaagagcgcctgatgcggtattttctccttacgcatctgtgcggtatttcacaccgcatatggtgcactctcagtacaatctgctctgatgccgcatagttaagccagtaagctttttgcaaaagcctaggcctccaaaaaagcctcctcactacttctggaatagctcagaggccgaggcggcctcggcctctgcataaataaaaaaaattagtcagccatggggcggagaatgggcggaactgggcggagttaggggcgggatgggcggagttaggggcgggactatggttgctgactaattgagatgcatgctttgcatacttctgcctgctggggagcctggggactttccacacctggttgctgactaattgagatgcatgctttgcatacttctgcctgctggggagcctggggactttccacaccctaactgacacacattccacagccggatctacactccgctatcgctacgtgactgggtcatggctgcgccccgacacccgccaacacccgctgacgcgccctgacgggcttgtctgctcccggcatccgcttacagacaagctgtgaccgtctccgggagctgcatgtgtcagaggttttcaccgtcatcaccgaaacgcgcgaggcagccagcttacctcccggtggtgggtcggtggtccctgggcaggggtctcccgatcccggacgagcccccaaatgaaagacccccgctgacgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacaagtcggatgcaactgcaagagggtttattggatacacgggtacccgggcgactcagtcaatcggaggactggcgccccgagtgaggggttgtgctagcttgccaaacctacaggtggggtctttcattcccccctttttctggagactaaataaaatcttttattttatcgatggtcaagttccttctggttctggctctgctcatcgtcctgcaggaccggacgtgactggagttcagacgtgtgctcttccgatctcatgttaactcgagaattctaccgggtaggggaggcgcttttcccaaggcagtctggagcatgcgctttagcagccccgctgggcacttggcgctacacaagtggcctctggcctcgcacacattccacatccaccggtaggcgccaaccggctccgttctttggtggccccttcgcgccaccttctactcctcccctagtcaggaagttcccccccgccccgcagctcgcgtcgtgcaggacgtgacaaatggaagtagcacgtctcactagtctcgtgcagatggacagcaccgctgagcaatggaagcgggtaggcctttggggcagcggccaatagcagctttgctccttcgctttctgggctcagaggctgggaaggggtgggtccgggggcgggctcaggggcgggctcaggggcggggcgggcgcccgaaggtcctccggaggcccggcattctgcacgcttcaaaagcgcacgtctgccgcgctgttctcctcttcctcatctccgggcctttcggaattcgccaccatgattgaacaagatggattgcacgcaggttctccggccgcttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggggcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaggacgaggcagcgcggctatcgtggctggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggggcaggatctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaagagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgcgcatgcccgacggcgaggatctcgtcgtgacccatggcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgacgcgtcccctctccctccccccccctaacgttactggccgaagccgcttggaataaggccggtgtgcgtttgtctatatgttattttccaccatattgccgtcttttggcaatgtgagggcccggaaacctggccctgtcttcttgacgagcattcctaggggtctttcccctctcgccaaaggaatgcaaggtctgttgaatgtcgtgaaggaagcagttcctctggaagcttcttgaagacaaacaacgtctgtagcgaccctttgcaggcagcggaaccccccacctggcgacaggtgcctctgcggccaaaagccacgtgtataagatacacctgcaaaggcggcacaaccccagtgccacgttgtgagttggatagttgtggaaagagtcaaatggctctcctcaagcgtattcaacaaggggctgaaggatgcccagaaggtaccccattgtatgggatctgatctggggcctcggtgcacatgctttacatgtgtttagtcgaggttaaaaaaacgtctaggccccccgaaccacggggacgtggttttcctttgaaaaacacgatgataatatcgccacaaccagatctgccaccatgcccaaaaagaagaggaaagtgatgtctagactggacaagagcaaagtcataaactctgctctggaattactcaatgaagtcggtatcgaaggcctgacgacaaggaaactcgctcaaaagctgggagttgagcagcctaccctgtactggcacgtgaagaacaagcgggccctgctcgatgccctggcaatcgagatgctggacaggcatcatacccacttctgccccctggaaggcgagtcatggcaagactttctgcggaacaacgccaagtcattccgctgtgctctcctctcacatcgcgacggggctaaagtgcatctcggcacccgcccaacagagaaacagtacgaaaccctggaaaatcagctcgcgttcctgtgtcagcaaggcttctccctggagaacgcactgtacgctctgtccgccgtgggccactttacactgggctgcgtattggaggatcaggagcatcaagtagcaaaagaggaaagagagacacctaccaccgattctatgcccccacttctgagacaagcaattgagctgttcgaccatcagggagccgaacctgccttccttttcggcctggaactaatcatatgtggcctggagaaacagctaaagtgcgaaagcggcgggccggatatcggaggcggatcaggtggcggtagcgtccccgatcgtaaggctgcggtctctcattggcaacaggacgactataaggaccacgacggagactacaaggatcatgatattgattacaaagacgatgacgataaggccaggtaagtaatgcttttttttttctcgctctcatttttcaaaaacccacataaaaattgaggaaagggaagaattgttttctccttccagcacctcgtaatttgacccgactgatggttcccattagtcacataaagctgtagtcaagtacagacgtcccgcggcttcgataccgtcacgaagcaacggatccggccggcgcctagagaaggagtgagggctggataaagggaggatcgaggcggggtcgaacgaggaggttcaagggggagagacggggcggatggaggaagaggaggcggaggcttagggtgtacaaagggcttgacccagggaggggggtcaaaagccaaggcttcccaggtcacgatgtaggggacctggtctgggtgtccatgcgggccaggtgaaaagaccttgatcttaacctgggtgatgaggtctcggttaaaggtgccgtctcgcggccatccgacgttaaaggttggccattctgcagagcagaaggtaacccaacgtctcttcttgacatctaccgactggttgtgagcgatccgctcgacatctttccagtgacctaaggtcaaacttaagggagtggtaacagtctggccctaattttcagacaaatacagaaacacagtcagacagagacaacacagaacgatgctgcagcgctgcagcagacaagacgcgcggcttcggttccaaaccgaaagcaaaaattcagacggaggcgggaactgttttaggttctcgtctcctaccagaaccacatatcctgacggggtcggattccacatcgactcccttcctcaggtcgggccacaaaaacggcccccaaagtccctgggacgtctcccagggttgcggccgggtgttcagaactcgtcagttccaccacgggtccgccagatacagagctagttagctaactagtacagacgcaggcgcataacatcaaacatagacactagacaatcggacagacacagataagttgctggccagcttacctcccggtggtgggtcggtggtccctgggcaggggtctccaaatcccggacgagcccccaaatgaaagacccccgtcgtgggtagtcaatcactcagaggagaccctcccaaggaacagcgagaccacgattcggatgcaaacagcaagaggctttattgggaatacgggtacccgggcgacgcagtctatcggaagactggcgcgccgagtgaggggttgtgggctcttttattgagctctgcttatatagacctcccaccgtacacgcctaccgcccatttgcgtcaatggggcggagttgttacgacattttggaaagtcccgttgattttggtgccaaacaaactcccattgacgtcaatggggtggagacttggaaatccccgtgagtcaaaccgctatccacgcccattgatgtactgccaaaaccgcatcaccatggtaatagcgatgactaatacgtagatgtactgccaagtaggaaagtcccataaggtcatgtactgggcataatgccaggcgggccatttaccgtcattgacgtcaatagggggcgtacttggcatatgatacacttgatgtactgccaagtgggcagtttaccgtaaatactccacccattgacgtcaatggaaagtccctattggcgttactatgggaacatacgtcattattgacgtcaatgggcgggggtcgttgggcggtcagccaggcgggccatttaccgtaagttatgtaacgcggaactccatatatgggctatgaactaatgaccccgtaattgattactattaataactagtcaataatcaatgtcaacatggcggtaatgttggacatgagccaatataaatgtacatattatgatatggatacaacgtatgcaatggccaagctaattcttgaagacgaaagggcctcgtgatacgcctatttttataggttaatgtcatgataataatggtttcttagacgtcaggtggcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaataatattgaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgccttcctgtttttgctcacccagaaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactggatctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgcggtattatcccgtgttgacgccgggcaagagcaactcggtcgccgcatacactattctcagaatgacttggttgagtactcaccagtcacagaaaagcatcttacggatggcatgacagtaagagaattatgcagtgctgccataaccatgagtgataacactgcggccaacttactt  B   8       &   9   .   0   #      !            8      +   1   (   !      *   (   %      !   &             *             !                                       .         =         %   (            1      (   $   !   /   '   !   $   '      '            *               '            ,   &         -   1         !                         (                                                                  "         $            #            1   ,      /   #      #   $                  $   )   #                                                      %                           A             +   )               %   $         /         $         !   (   *   *      $                                 $   )   (   &      '   %   )                              !   A   #      2                     ,   &             %   (         $      "      (   ,      !       &      "   2        8 2 3 Ly°±²VW§¨©Kl�¼ÅÍì—	¾
÷
 ·zLU…Ë=&'1mno“/4ë8�<=ÇÈö  4 O zKXq†½Æ¸˜	ò
–›yÌ…;^(i”nÿp´§÷& 2{³3wSG�žÎí’	²
ø
ü
½MRp Ë0}ˆ¥ 5d¼ì‚ÉÛç9 M§ªLWamv‚†¦Ì	¿
å
!%|Øl«¸{T"V†±>ºÉŠö2]¬S/Äó9 >gÃÑá©f.   V Ú #{Ë>L®Pez¾¹Z·	_	™	²	8Á†œÕÞ<n–êï):CIjoùw=†0 P 8Y·fl[hF
w
¬
ó
…—MãÞ(c€�Á.IrñróYY_= …µÕPŽ÷Ž¨ýøb# 5 Ö à ‹g½•r5}–¡½Ib³ö$^zØ�œõØû65š}ö¹  í €‡Ç&ºP	U	j
˜
Hœk"Í+ÓÔà•qôDY! )ª®ªüÿé
ù
¾4àéÖ�¢S¡²Ìá‰%cƒé½Ü ;VÀÛ!(c}—HŸ“	
³
nj\¨te½ÏPP ±|´xÕŽÖËŽÏ5	­«Ó�Úÿ:Ü~íÄÙè• 3£4T
î&	ý
0TNlÂq‡›Ôb1O¦!(6ÊÕu8 « Ý f›«MXbnwƒ§¿œ	Ô	
"&m¬ûž®ÆJMÏõ‡™¥â3FüÒÅÝ:?œÄÒÞMK � Ä ‚/–éª	Í	À
@ÙN¹»ŸÄØÿOÍ0Hhì–g½+ âY¨Z‡;	
æ
î
	ÆÎéV_¡íþ|—	.U<W?‘Ê¼¿÷L^~Ö«ô1 þ NÊÜçî"(â	é	!
·
Æ
;}µcêÐå#0á‡¼e²»Ti‹Þ­îT`„
!â�ªõ(  Û IdÉçX‹¸Ëš	ì
9ÄL± ©Öñ—Wô;ADJkÒúu©é! ¤qãú?Q�å[p	†	ÂÜË^�øúoëê*,§x�‡9Ê |:+Xf{Ç`	¡3‡øðpå>šflã™æ*  W r $,JÄìÌóAMŒ¯/O`p¿º*³	¥
9=rDA1Œß*=@µH _2l(  ` ØgmG
x
­
ô
-‘˜¯NoAÔ}��š[gVb¦ò`Ðì>ÖŸcÐ% “[üZ¸Þ6Þ,ä)/Þs`jsôq�Zµ—çTQ�ø�¥ù\µÀ« \ Sˆ	†<×PßdtJc¶ŒÌ! Q ® �&¬ÐÞ9G\i˜@ŠÂÄ©ŸBZ²‘†©þñ!& € × SŒœxÄsŸç~#	•
žòñJcÉ_ç¼Í�7�Ï¶›´ØçXÊ/º á ¦ói‹–å4—8ö%ê�üÅü¯ÿOx~²ÐGê µåé“”¢÷}	6•]&   6 H �`hs¾6 v	¾]f´{€ýÙ�´öÙÀDÓ÷* o vˆyƒ'DV	g	k
Ii…l«ž«>Îj:Õçµ.öÏö,rÌEÈx2…º¢â`   x ™#e¤p
™
â#�Ò,mÔü,M�£©ÊæíõùHZ;Â Ò �‡ˆ•ÈÝOª»		[	Ô�ÿ'Øí‰6AÙ‰Û�  î Ë'RÔK®:]rQ	'+!¿Y°3á„c–º[Xz�! 0¯Wdý êà	
ú
¿]á,Ñ¸g£r&bñ„eêåI v *8ñš-^M¬ÉY	n
½6{¤ò³Í>Yç˜°¾è 	qÃj	ûêîŸ‡T¢Š}[ «¹“«Ól	e
�
5²eì×Ž&F}âdþÝÖ hX-I”	
{
´
«è©¨�fäô < WÁ…Ü)Ø¸#}uÐsíö QÄÆ <c"d~˜âoðJu]Ð†-hnQ ¶ Ckšf¨°VÇ¾·êB[m› L ˜ ç }�×Ðˆ+q!)‰ ;î@ZÎVØ]– kP�Ïh}~	Êü¬Ûù»CŸñÅé Ñ<²¶yÌ�ð¡ÔhlÚ¦% BµÖ÷,	6	b	
J
g®ýp�£‡�/‘ ÝŒ›? n¤5t�zb
Zºx¦Y2P"_Ëv. ~ÇN£ZBUÅÕL°'	B
"‹Æ58ú‰›«ËrˆcŸ—i2{œ,5ˆ±½Ö8EËå¥ 4sŒ²ï®	‚
‹
[Uô6Om§·"ÃœÕç"{u7Î  oH	þ
10°±®¸¤j§)Uü“= Þ 9¬¡-¬Èj{• NYcox„°
Ä
#T”ùüK¿ß¯…ˆš¦À½4GªìÔý‚;ÅÓßûN”Nó ¬ gÎVbån¨­*;¯ÇN®Ðö8B‹ÆÖ t .LƒïŽ`
n)®îHÎ¬0@�% › ø �îœ CQr^|ãÀ�	¹	Õ	
*
'Ub
Rw�Ÿ¡…ã¿ÒÓÞà L( ‡ ê Déðž0ASêM	«	Á	Y
g
’
Á
Î
ªEOyº‚„¸¼Ž¼ÄÇÏ1ËiÓ Š � � Å ƒ“Ãã�‡§
ôhÿ3Å �ë$ÎÓëž¥Šhn »�¤Ê/¢«êó—¿µ	A4t£‡CÙHáÕÅI—|°¾ ) G0»E­Î	ï	~
�
HW¦Ú?� P£víß41 Y ¡ŒZ]©ä1’¹Ú[v©¼AÉ	¢
ï
dê`|¢îÿ
>VX‚Ð#Ë,½¥ø¹ÁºÍØ  ¥ÆGõBHÕ×	ÇÏW¥/@w·¿¤•D( ! ½ �ãÇOÜ¦îˆ�ñÙŸ	»	Ñ
Þ
L¹ÐîF]gÚ“–’(ÀM_×¬N$ ú BŸï:¿�<	A	n	
\
Ö
ç

í�Ó}˜w=Dz¸({¬7Iõ3¬! &º>DÇ2_¶õø´ÙQ‡ÔëtÑ×æµ?Œßä…âcy/ c O`~¿ÔFlíÝ

,
Ç
Œdƒ“]âéó¼y®ïU«f¼ï"`Úãa�Ûö' C ƒ ­5_±ËÝè%téïû#)µÁý	ã	ê	¸
~ÌŒ–Ùˆf‘HUjå!«·ž! ÿ [Â`~,ÂÄ	"
T
)<7§$1b½
³¿êV€aJ(­‚$ 2JU¦k€ŒÌ–	ö
šy!KT:]õ%Q\hl’m|3ê;¨'   ì f=eYg¹O	E
i
G¼a²!b]q×ÝòÓßôXî<Bv„öa ©Ú Êè/¬kÕiª¡†±ÓàþaNÃè' Ü �šíè›	©	
¶
í
:ÅM–�äº»d×ô�˜»EK}ûÑªÝ Ãë@oÈWŠë
ÃqC20]ð÷ùé+@¦´t¨ekÉ Z%ûR‡	Ýf¨_žpbë–±�´ ‹ªË Rœ¥ä_ròäžæ”
�õüÌ®þæÉÒ* Ñ ˜ÊQ‡£9\q	f	á&œ&ûì
´-¹Œ¢¨ÉÎõËåìøWyŽØˆ¡á: Vc,]Èß	±E|ñXqædäÕç µ×z
áeç"¯ÆógmÃšÅ æ jÐ;ŽÎg|+	a	I
¢† (ˆšº?kð×> }mnYAKy¯­	A
Š
4¥7XùšªzžihÍT›û’7¤' s -K«í Íîÿ,B�PUaiqm¯
Ã
T	Q“):(„­¾G®„«A¾ŠÕ  ‰ Fºè/Â´	À	}
œ
¦
Í
>sBƒ2�Œàê#uÒÆê¤3m¯  X ¼ ÅÆôN0Û¨»ðØ[
Ð
{E’�z+v¤¶¾” b %ZÁ°CÓèúEÀ1ì+Ã	P†Öè�>xIÙ`,  eÙ™f¨	õ
.™œãaj~S\hcpó�ºÞó\í $[|ßý`lƒ§`& ^Â$†n8‰œ%pB›ô1/§ïö	a?¸ÍV§× dÈÑjÈ å Ïlx*	Þ	H
y
°à6WDæ{!®hSòúc‘ïÂ= a Y¹þ+hÒÚçù§®
S’(OÕ‚‘çF€­"ƒ£Ñwé“®- ä ]dýæø7Rß`æ05Cîõz‚[¢ÿZv·ÞüègURù�¦_ÁÇ<­1 î+\™š›œ¹ºåõö÷789:;	Qåå¯°±²ßà~tíDEPQu¶íîZ[¿]^Æ¬ ”,ù3<2		s
æ8uR�ï=P�uiú'J k Ÿ ï•�[»ßà-* ³á=takrFf˜â\ß imŸÀ¶! ] Œ T3t
©
=öçQeu9S%Q5~‹ÀBSjŒÈÖûK,� Î •ú4	Ê
Øàí‘·Òß8v0;dÓ(>SV Ê ü=™á‰	‡K&Sd…ð"˜Í -‡JºO³	åÇv_ð>l‘>  l • �5­Ñ\¼ÅHàÇ¤´ Õ³]øƒ·"  - ’ Ç –:oj™Þ.¡PâªZbsÐw™¬Ùà‡¡jªHtýí >   § ¯ …ÃðÌÞ'ß]ƒ�	A‹>u[g’Ânÿ3òpù  R žá
+ÃÅølCGÆã ÁAà( 0 � Ø T‰µ¨IUtŒX$	u
–
ª
ŸëKÄÞèR:wýŽ86ÍŒ¥Á	K{�×» ^ �%ø4’Ò>dèTúÐRÙM]vÎ7j-0ŽÀä : õÁ|	úv� eŽµè	YôCTkÉü+G � �yÅ ¤èì·	óò÷¥Êf`”½Î&¨·œˆLËÑ Ï –§ŒlÌË
&&ãÓ9Á  â j—15	áòë;ÜN ý× 1<gÑÔ?HTÞë ÙÛ¦Ù9ø	îc‘ý%Keqy)W f Ýôû;æ5­õ˜÷ÞÆ’°¸àPw­³~ A½æšâ“•£¨;rÒ'ÊÿTe±ýu±/‚™·#Y ¤ Ë ¶>L—´'-sSÎ êöý”€š	ÿ=€†,K^%æ»w™ *öŠ	õ	CˆÊø~EL
ñ7–™#pˆ… 	 I ežE´ 	E	æZ16üq‰“ð_È5“µ>ñÒî 7 >a¿ØPè^vÛÛwÚã7`ž÷ÜmÇ?Ô n iˆf�»7	w	v¿Égµ|�þJÁ/Pø² .tK$™!ü	äÚòE'?’§/	V w®Ó„Eœj¬lÉ;èÖ/÷-^£º·   m p ~ t‘‰ÒGI(JgmŸ?åkhÖåÎ‹´F“F£á – 6KW	h	l
€
Y†AÈ¥ìµÏ¢¶÷ syâ3†¯»„ã# ]½Æ‹záJ¨¬¡ªÐÍÉ«ùµ¸a  š¿ì;/¡kæš
ßÓÕ[ctÑ²x”œ¤¯²Éöüˆ¢þ¨Ã"  + “ È —¸¥vÜ	q
šÜãž¢
Qö-n« ñXŽªËXîk�< . 9ó(ó	ú	/$’›3Lž-N#<ÚáI«I[o!uì y r½ÙŸÐ$&;fpšÚ	ñ	ùãÄýš­çúR€î$ ¨ Ó I²ÄGßýà^ P„¼\	ÕBŽžŒ Í(œ¥ÆŠ7Ú¹ì]óð ¡ ° †‰–Þ
	‡
\ÙîÃéÜ¢*4‚ ³ ò ßñˆ¯É÷Ð	ä¿hŠDTï6‘úþ ? · ÕÍ(‚¯=S«‚	6
E?OvB“poy q�#   S ¢2x’Û"7L¡¯ÒÛR	�	 

Ÿ
(ZÈ3ä%¡Â)pê h { ï Ì(Ÿ¨ÉöSs�"%Æù4â  �Ê¡á =Õè�Òõâ/
,Î,ËûÿDx—»Ç\ Shr;^¢À2±Äm•àRmH…dY{À~B°1 1 N 1KJV`u»ÄRëË	½
ä
ñ
û
¼×ªSx„„¹ÈŸÊo.c³ò7€f¦ÂÐ
Úæ, Õ Ù "ŠÊ¶•	^	±	v
—
«
 ÀLjâõÝŽ#-*HÒðq›ÔXmú9O…��X|õ U¿°b©�Õþ	%	4	
ßÒ�š9s'bÎØ¼”/ Ž ª 
áXeÛæY¾:	Ó	á	è	 
^b ìÅé-IÏ/Î;žÃþh¤Ì~	ÜG›LŽëJ¼# +£9Ipâòù‹*._œäÊ¤
‹)VóÑ?èÿ™^8k1˜å [ _ Ž«5—;?�@s|™ZÝU¥´Sž[¿Ï# G ´è›3wÃ“ñðe7éûŒ¿Î\³NW%w±ÏF.é$  w &†”Ü"Nx‚­CZ	o
Ó¾X�ª=iƒb+Z+wÚ1„¹_�Á ™’«ÂÒk	~ë+ž%†f=ðýH ; 
,ªït™§§U�¶é
Zõl, µOö}	füŽûp .g‹BU¥\ Æÿrs‹Ä!/ŠÅYó5w!ˆ°£DÊ~ š ÷ € z”]¸	vøíÞÍ~¿©�/ÿ“ò$ ( † é C’º¬â.¡ªéò¾€†L	f
‘
G¥Dóg·þ�G»Ã�‰ÞÒ) ‹ŽF\žãî¾‘¥¸Ùí �Ô@	m	Õ
ì€¤ÒÏ=f•C·Ï''¸M«ÌC×# ‚ ¬¹_Æ´üÜ^ô6³Ø¦ËÓØa	¾éGãe»î_�Ú ¨
ìj•	
µ
JºP‘
õ:Â Ð —ãY%èäëåà i�mÍ@J@
‰
'¤™©¹Åg6 » .×¿	|
Ì
'¬éª½Ô X¸k˜*ÑÙâó¹Ý _kîÇ ã í 26		®<ByO¡þÝûthIÅ; Í û†I˜àì^$~„ÑÞ!/=R—ÇÒÕU  = ¦ Â4Ý€	ÆÅvÁØ÷2@ßì ˆ÷´§‹ÑùvdL¤óuz‡*iFÐ ÚÜk÷ñÛ
fÀ £ ™’	É§:þ
KÑþ°ü˜¶,rºXo‡R„ =dm#eD	YãÚp’ï^’&Ñ¦.U ÒŠJkg©¹Eá®´¶ q8Øë·: ™åÙ	øšÃð±W“±ÈQn€ ë ² ¶ ÔÞü®ö5
DÌN›¸ëC\x¡)œý g §Èõ<Rw‘ç!6ô¡Ž	1l”ßÇ2¿$(oé M ¾~É”Ò	
¼
»©,HÜ"ÓË²NaŒFšÏWÙ“% F çoŠ)›ã–
œ<r˜ÜŠ( U‚a¾*þ[v²0Vƒ¸$�Z^— ´˜ŠÑ ‰Xò*sf<ïA ' ™ è B‘¸âíá�©ØñÛÔ
¤uÑÒ<¶€.’œª â?i~¾	£˜O	¼ß ¥ Ì ·ìúÿ3Ð	­ÄÜúj.Æ: lj‘		ý¯û	µòt¿†TÏ µ ÓQv�Ñ ‰ŸójË™MÂD'n è(êµü & ³·—áì(à¨ð
»
Ó
ñµÛ�-M`‘›© ÒáëùþiÐ�		½	i˜¢Á®ú&mç¾9A # $ % ÷ø=xyz{ÑÒ•–ÎÏàë�ÞßÍÿ 			¡	ð ÕO*+,-./0>?i‡ùL_¼½ñŽ��š§¨&8  >|Ózû‚›ËÎò	¢	à
�ñRÖP1@jSˆÛòx' ?¶{'
Û
‚‰Ë�0QÂÙ—ó óå!œÏóc	NùMA!‰ò�$Pq+ ô l}øƒ±ù	1	7	‹	
2
á
Dh¯ò�™¤§9•æ”2k'šÜ@†) ¿ CÔ	Q×üÌ+÷-	r	£	ö	K
pþq_FSˆ×‚Kq’�TÞ8Hœy‰¡( 
 ü ¥6u&{µƒÌçG‹ZMR”ØÚ3Qò#˜Óôs ‘!	„	ƒ7[ý§`ºÉ1Ã	K?ï J f@o·¡F	c
Ž
[¸»cy¶{•`Ì® A 7Ÿ@|<Fí	(
^
Ü
Š2‘r€Š”[ñx6}5ê€w% ÈOæ¤[³CÆU­d	C
é
_wxŠÛ8ŸŠ óLŽ˜r×æÕ‰$ bÀ"„M±(	O#š6DNQ|äB¬"sdÝj3|�6‰¾9@F%Qrû 8 ?×ô#VÖôC	z	tÇéÜú9ÜûaÈø;-²Ì5 °ñ�ÐÙQ…
ŒÌ1œÌ‰nÈ®Ÿ¦/ õ  ~‰*D„�¼Á	,²ú�	2	8	>	¯	æ	â
E\ïhó¨nŒ¨Ü}‚ÿAFç	®�	|A ¹ o8Œ	3
�õ¸#0Ï jmÏtgùð	p	
nVš¥7:P–Â%(Q÷›Ý³$ 5!„±³x	ƒ
Œ
iw°ÀÊ¶¶Y?*/K•ÄÆ39lÖè#v8ù‡ Õ%?šµs	
ÿ
5y²ÿ1 ²ÛóF¨0z DRòÍ,÷	ý	år¥Uß9�:¨{)! uLpØý†þ.	I	8
Ø
2kqrÂÕ`G‰AØ,ƒLn(I¢
( À _/
’ø"bø¤	;
L
y±¸¼T—¯“¹‚Dkx*@Vq“ý”ŠW* xz¦¯vp……·F�¥‘	±
${k•¶Ê°<‰0«þ.R‡¤»ÃÆàõe*  U ß ¼”7­kOZdy4%|¶T	7„H'ÀŽ•›é×5Hø4óC™Ô<ü¸ (:­¢'Ô|–û
3SmèŒ[§ÁÙÛ$ÔOOt$ Ã ý .É!'•
Å
?´ÍèUúý­LàNS†¾ÝáíÕ_ƒ•ô q HNWcæ)oÆ…	KÛ8<° @¨Ê÷
GŒäâ  ­ ’×ÏÝFÝ,®+n‰ÖOÓÃaiA€Ïæ¤ð   hŠ’"	u	\È|æ»³ÄŒCµ”× n uÓJd©*h„ ªþ¯Ñl92×æˆõ5L@ÇG u /7p¸ðLX	i	d
m
�
ú\¼5dzíÐ£·a—¯|Z bgW„BIÏ·|ãArì… K — A
o‡*Éï€øYžÍ$ M�¢±ÔG	a
�
Z¹¯¦¶­·Êæ!t–^1z+4‡°¼ä 8‚Ç{âä)
_
aS€ ­7~¼ëÑÓßúM œ ï�D@RŒ£Éî	X
V©x3¢�†¢ÎÔÊÄ{$   ù  ¤A9AGuœ@ž	º	È	Ö	¡
Ý
Kc¸í\vÙy"«6HÀ£2¹) B 4^}¾$=s_k}Á	
+
S
(‹÷‚’s‹•\òU´äªá '¬¶�bx( ë €1<T¥çN	D
h
«F»`x• ¹ÔÖÜ9 Òg…°M{Ð2Üç& Q›ÉPêñ¢ÇVe	“
ê
àeû\³‹•¡¥°Èô�­³Ê÷ýs³Š© Ub\´Ö®¬	…dWy�™ÌjÖ£ÄÔ' ˆ EªçŸÀÅíÁBTD0ëïlÂ	Z
›
Â
Ï
Pz…ƒ½�y‹ut½Å‰£Øÿ% ÎÁ#…¦ewˆ)	§	Ý	›$'›iER.o¬Žå!ò­#{Ì‚¦ñb’i) j ž *c”˜øäô1ßr
P_Ÿä 74}ìCYte�áìYfÞ<OŸhlž¾& ‹ É ¹N²¨
É
äõRÆ%ïk4}7Š¿:Ac‹=R+  , ‘ ” Æ „ËÄn‚
Ý£O÷YÏÔ«G‚süoø / 9 $ôH£ëWÀ{	¶	‘ê¤ÃÝ“œüù§ÌJ\Í6¿ã e Ø:¥Ë0¬ô%:ÝbMŸ$Öâ J¬p}Ý @¼õ)õô	BDqÉ<–+Jt°$.�³å"v˜ Ž˜×D	û	uÈç05uûˆÚ4Iâ6ñ.O=ÛÆí± } sF›
IX§f@ëÈä¡äÍŠ¢’ªà * ¼¾òžÏ%'.uÛ	ð	ò	ù	Û	‘õ2K�›®";Wû§ ñ H±F®<RÏ	†
�ã¤¾ÅèoSî5�ï! z ¡1Ú€ ÑgqÑÚÿ	.
ž
ŽÍ$ÊúQþwŸÉ}¯ A © Ô 	!JàaÚå
_ºÃÔQ½	3	9	]	°	Ê	ç	ã
ð
ÖaŸiôÎ.�Íƒ)Gƒ�ÂÑïpšÇWlù™žÉ8}n-Û»ô#   Z ¢³Hªá…2vÂ“Û!w�B£
ð:�ï?W©Y~h‹*EÎ Åþ+Nr‘ªe.}Ä�4o©˜$…¦¯-¦¤2 … ö Š�E[^ÿ½-³·ûÿ\Ž½…?	K	F]ëC£× ÎÝý B¶è
ÌF¾
ºÂºí^BÙñ º 	ëÖ?
ˆ
I¹$ç¸Äê5  H—ß	ÅA]x^ƒÀÝ– ¢ ‡ö³ŠCÈÐX¦‘öÚÐ¥—£+¹Eƒ ± p¦Ç7×ê9Iä�	Ø	4
0“ï1# E n�È‰‰ÚÑ	ºtÐ	WÑG›Û;—`½)‹EUœ’ ´ 2uˆžòNÃiÞ…´û, " àwÐhÍßêú'Ý§Êïñþ	 	¼	
º
Ò
ß
€ïhQ´—ÚÀN)R­øð�7& ¾ ó òkä P°ø0	q	&
1
Ú
Mo^Ž˜¦8”å“JpÁ€&ØGO  @ û 6? ;%ƒ	ì	]
�
‚F~·bZŠw¹L|4z×éJ”­r  ¯Ö"ƒð² T¬B	y	„
è
sË™CP{0Ç:Kq4­úˆž ¸ Î)Cƒ°À+=	o	å	mîµX‹Û>@E).­Å8$ö% ^…ñý>‘´÷a
7
:
×
4jx±ÁÔx·»@+–mCw9~pz( T Â '»y“&3”¶ú$¤S	�	

 6>z³ 2µRç&�Üà†BÂd  ÖÜEMcÜÅt	+)Úˆ©Õ{ÒÂ@²‡ô4åã aV°Ó
ù4¶Éå]X–*që{Y$  £3#8?¢È@jt›?Ç	R
W
 
`·öì[uØ!T³»G©&¢Ã1z P©TaÄSÀÕî„”dúsf„¯Vz¬Û²¢" i Í)Ê÷óm0dÞ¦	
È
&^ãXzàe;N�g½ðab‘*÷ d G�æÂp5•¦ð*s¯Ëÿ#€äÜâ( | ð E Î-tø	þ	-
�e#ÉêÇôâ½ãJ!:Vž¡‘©|, „ M`qÙþ
u¶ÂÓþ
€J	-9ÃÖÍ-3Ìüg—µÁîo„™EVk˜È)m,D£ 6Öé²êã>
ÄH’ æ]‚"–¸
! D 1vÌÞé&‡ý/	%
0
¹
Ù
sÏ�—³ÙIMo¼F„ŒŸ  ]®>‚ðüÿ$*ö`ä	ë	9
3lra´ºWŠÚB‰-yJ}¬& Á `Ubis“ù#>£ÄÆ	Q
V
*=¨3z%ÁS±†ºA\ÁW•X Ã/c¥	ÁÈcoáWI”eƒdyM€)r®þ±"  \0	_ü$
=
8³¹Ã2V²–´Àín˜�El+|•	Cƒ‹2 Ta-.<=ÃùúûÅ	#
<
M
N
O
P
U
²½¾¿ÀÁÂUÅÆÇn¾¿Àëì°bcKLZ[”  1|  qGACNNNNNNGTC,CCAGGCCTGG,GATCCGGATC,CCWGGTACCWGG,CCANNNNNTGG,CCAGGNNNTGG,CCANNNCCTGG,CCAGGNCCTGG,GCACNNNAACGTTNNNGTGC,CACNNNGTG,CCNNNNNNNGG,AACNAACRYGTGCGTGC,GCACGCACRYGTTNGTT,GCACNAACRYGTTNGTGC,AACGCACRYGTGCGTT,GACNNNNNGTC,GAANNNNNNNTTGG,CCAANNNNNNNTTC,CACNNNNGTG,AACACNNNNGTGC,GCACNNNNGTGTT,GCANNNNNNTGC,GAACNNNNNNTCC,GGANNNNNNGTTC,CAGNNNCTG,CCAGGNNCTG,CAGNNCCTGG,CCWGGGCCC,GGGCCCWGG,CCWGGGCCCWGG,AACNNNNNNGTGCACNNNNNNGTT,GACNNNGTC,GAANNNNTTC,CCWGGTACC,GGTACCWGG,CCWGGWCCWGG,ACNNNNGTAYC,GRTACNNNNGT,CCWGGYRCCWGG,GAAGNNNNNNTAC,GTANNNNNNCTTC,AACGGCNNNGTGC,GCACNNNGCCGTT,GCACGGCNNNGTT,AACNNNGCCGTGC,CGANNNNNNTGC,GCANNNNNNTCG,CGATCNNNNTGC,GCANNNNGATCG,TGANNNNNNTCA,TGATCNNNNTCA,TGANNNNGATCA,TGATCNNGATCA,AACCTGCNNGTGC,GCACNNGCAGGTT,GCACCTGCNNGTT,AACNNGCAGGTGC,GCCNNNNNGGC,AACNNNNNNGTGCMC,GKGCACNNNNNNGTT,CCWGGNCCWGG,AACTGGGNNGTGC,GCACNNCCCAGTT,GCACTGGGNNGTT,AACNNCCCAGTGC,GACNNNNGTC,GAGNNNNNCTC,CCWGGTCTC,GAGACCWGG,GATNNNNATC,GATCNNNATC,GATNNNGATC,GATCNNGATC,CCWGGCGCCWGG,ACNNNNNCTCC,GGAGNNNNNGT,AACNNNNNNGTGCAG,CTGCACNNNNNNGTT,GATCATGATC,CCWGGNNCCWGG,AACTGGNNNGTGC,GCACNNNCCAGTT,GCACTGGNNNGTT,AACNNNCCAGTGC,AACNAACCGGTGCGTGC,GCACGCACCGGTTNGTT,GCACNAACCGGTTNGTGC,AACGCACCGGTGCGTT,GCANNNNNTGC,GCACNNNNNNGTTCGAACNNNNNNGTGC,CCTNNNNNAGG,GCNNNNNNNGC,CCANNNNNNTGG,CCAGGNNCCTGG,CCTGGCCAGG,CAANNNNNGTGG,CCACNNNNNTTG,TTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAA,GCACNNNNNNGTTTAAACNNNNNNGTGC,CCAGGNCCY,RGGNCCTGG,CCWGGGNCCTGG,CCAGGNCCCWGG,AAGNNNNNCTT,GAYNNNNNVTC,GABNNNNNRTC,GAYNNNNNRTC,GATCNNNNVTC,GABNNNNGATC,GAYNNNNGATC,GATCNNNNRTC,GATCNNNGATC,GTYAACNNNNNNGTGC,GCACNNNNNNGTTRAC,GCACNNNNNNGTTAACNNNNNNGTGC,GATCNGATC,TAACTATAACGGTCCTAAGGTAGCGA,TCGCTACCTTAGGACCGTTATAGTTA,CTCTCTTAAGGTAGC,GCTACCTTAAGAGAG,TAGGGATAACAGGGTAAT,ATTACCCTGTTATCCCTA,GTTAACNNNNNNGTGC,GCACNNNNNNGTTAAC,AACNAACGCGTGCGTGC,GCACGCACGCGTTNGTT,GCACNAACGCGTTNGTGC,AACGCACGCGTGCGTT,TCCAACNNNNNNGTGC,GCACNNNNNNGTTGGA,CAYNNNNRTG,AACAYNNNNGTGC,GCACNNNNRTGTT,GTTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAAC,CCWGGCGCC,GGCGCCWGG,CCWGGNNCC,GGNNCCWGG,GATCGCGATC,AACNAACATGTGCGTGC,GCACGCACATGTTNGTT,GCACNAACATGTTNGTGC,AACGCACATGTGCGTT,TGGCAAACAGCTATTATGGGTATTATGGGT,ACCCATAATACCCATAATAGCTGTTTGCCA,ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGG,CCATTTCATTACCTCTTTCTCCGCACCCGACATAGAT,AACNNGCACGTGCNNGTT,GAACNNNNNCTC,GAGNNNNNGTTC,CCAGGWCCY,RGGWCCTGG,CCWGGGWCCTGG,CCAGGWCCCWGG,CCAGGWCCTGG,TTATAACNNNNNNGTGC,GCACNNNNNNGTTATAA,GCACNNNNNNGTTATAACNNNNNNGTGC,GAACNNNNNNTAC,GTANNNNNNGTTC,GGCCNNNNNGGCC,AACNNACTAGTGC,GCACTAGTNNGTT,AACTAGTNNGTGC,GCACNNACTAGTT,AACNAACTAGTGCGTGC,GCACGCACTAGTTNGTT,GCACNAACTAGTTNGTGC,AACGCACTAGTGCGTT,AACNNNAACGTGCNNGTGC,GCACNNGCACGTTNNNGTT,GCACCCANNNGTT,AACNNNTGGGTGC,TTAACNNNNNNGTGC,GCACNNNNNNGTTAA,CACNNNNNNTCC,GGANNNNNNGTG,CACNNNNGATCC,GGATCNNNNGTG,GATCTAGATC,CCANNNNNNNNNTGG,CCAGGCCT,AGGCCTGG,CCTCGAGG,GATCCGGA,TCCGGATC,GGCGCGCC,GCGATCGC,CCWGGWCC,GGWCCWGG,GATCGATC,GATCATGA,TCATGATC,GCGGCCGC,CCTGGCCR,YGGCCAGG,CCWGGNCC,GGNCCWGG,GGCCGGCC,RTGCGCAY,GATCNNGA,TCNNGATC,CGCGCGCG,CCTGGCCA,TGGCCAGG,CGCCGGCG,GTTTAAAC,GATCGCGA,TCGCGATC,TTAATTAA,VCTCGAGB,CCTGCAGG,CRCCGGYG,CGTCGACG,ATTTAAAT,GCCCGGGC,GATCTAGA,TCTAGATC,CACCTGC,GCAGGTG,CCTNAGG,GATCGAT,ATCGATC,CCTCAGC,GCTGAGG,GCTNAGC,CCTNAGC,GCTNAGG,GCTCTTC,GAAGAGC,GGTNACC,CGGWCCG,ACCWGGT,RGGNCCY,CCTGGAG,CTCCAGG,GGTGATC,GATCACC,GATCNGA,TCNGATC,GGGWCCC,GAAGATC,GATCTTC,CCCWGGG,TCCNGGA,TCCWGGA,RGGWCCY,TTATAA,AGGCCT,GACGTC,GTMKAC,TCCGGA,TGCGCA,ACCTGC,GCAGGT,GGTACC,AGTACT,GGYRCC,CCGCTC,GAGCGG,AACGTT,YGGCCR,RAATTY,CTGAAG,CTTCAG,CACGTG,GRCGYC,AGCGCT,CTTAAG,ACRYGT,ACCGGT,ACTAGT,CACGTC,GACGTG,GWGCWC,GTGCAC,CYCGRG,GGGCCC,ATTAAT,CCTAGG,TTCGAA,GCTAGC,GKGCMC,TGGCCA,GGATCC,GRGCYC,ATCGAT,CACGAG,CTCGTG,GGCGCC,GAAGAC,GTCTTC,GCATGC,GTATCC,GGATAC,TGATCA,ACTGGG,CCCAGT,CTRYAG,RGCGCY,AGATCT,GGNNCC,CTGGAG,CTCCAG,CTTGAG,CTCAAG,CGATCG,GGTCTC,GAGACC,YACGTR,CCNNGG,GAATGC,GCATTC,WCCGGW,GCAATG,CATTGC,RCCGGY,GCGCGC,GAGGAG,CTCCTC,CGGCCG,CCCAGC,GCTGGG,GTGCAG,CTGCAC,CGRYCG,CGTACG,CGTCTC,GAGACG,CCATGG,TCGCGA,GDGCHC,TGTACA,TCATGA,ACATGT,GTATAC,CCWWGG,CTCTTC,GAAGAG,GCNNGC,CCRYGG,GTTAAC,RCATGY,TACGTA,RGATCY,GCGATG,CATCGC,GCAGTG,CACTGC,CCCGGG,CCGCGG,TTTAAA,GGCGGA,TCCGCC,GAGCTC,GATATC,CTGRAG,CTYCAG,CAGCAG,CTGCTG,GAATTC,ATGCAT,CATATG,GTYRAC,AAGCTT,GTNNAC,TCNNGA,CAATTG,ACGCGT,TCCRAC,GTYGGA,GCCGGC,CMGCKG,GCCGAG,CTCGGC,CTCGAG,CTGCAG,CAGCTG,GTCGAC,CTYRAG,AATATT,GATCGA,TCGATC,GACCGA,CACCCA,TCGGTC,TGGGTG,WGTACW,TARCCA,TGGYTA,TCTAGA,GGATC,GATCC,CCWGG,GTCTC,GAGAC,GCWGC,GGNCC,CCSGG,GGTGA,TCACC,GGWCC,GCAGC,GCTGC,CCATC,GATGG,ACGGC,GCCGT,GCNGC,CCNGG,GCATC,GATGC,ACTGG,CCAGT,GGATG,CATCC,CTCAG,CTGAG,GGGAC,GTCCC,ACNGT,CTNAG,CAGTG,CACTG,GACGC,GCGTC,CCCGC,GCGGG,GANTC,CGWCG,TCNGA,CCTTC,GAAGG,GTNAC,GAAGA,TCTTC,GAGTC,GACTC,GTSAC,GAWTC,GCSGC,CASTG,ATGAA,TTCAT,ACGGA,TCCGT,CGCG,CCGC,GCGG,GTAC,AGCT,GCGC,CTAG,GATC,GGCC,CCGG,CATG,RGCY,YATR,ACGT,TGCA,AATT,CCTC,GAGG,TTAA,ASST,TCGA                                        7                                                                                                                                                                                                                                                                                                                 +                                                    	   	                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                         	         
                                           
      '                            '                                                                                	         )                                                   
                              (                                                                                                                       
         8   0   
            
      
         	                                 "                                                   $   =         %          1   (      ”   Z      $          (      m                     7                                                                                                                                               +                        	 	                                                                                                                                                                                                                                                                                    
         	   
               
  '          '                            	   )                 
          (                                         
   8 0 
    
  
   	           "                 $ =   %    1 (  ” Z  $    (  m   }¼  @  Z  ¬  „è  ŠŽ  ‘¨‡ƒ'p&ÌÞG°öùú>?_tÄÅãý�	þ	
=
 ù²ÆpÂ–ì�‡æef˜åFJ+,;[\|‘ãvDr[«óBUê
Oª…–,È�!š—”n›ÿ ¸
Ù`ÚÝX<¤¢êæF‡ ÿ ƒ¿1r¤ o¢ê»	Î	§
¸
Þ
LWnùÿt˜ÇÑÐÙÿ¯Ð£¬?¤¼@`Ú�©”O!v6Drg	¾Ï[6,vDr¾Ü[6vDr¾[66¾¾{z ÃÆvÝÕ¾
”(ñ:”Ÿ;ŸP	Ý•ö-•¬¾]fÙöJ	ú]J¢

Mn	moAÒ—/!…»±”¨™k {s	}Ðhely+µ"@/”í¶
dµrx2…ºâ5š vûDªŸj½šªŸ¿
&4ÖjOâá½c8uG1• Ç"Å
´béÏàÝíƒ	Žôˆ	†ï�?YÎäë¡¿
&µârx2…ºâ`¾ióh	¬ì› 
‡
Ã4
XV	g	k
Î¹«l	=Ž& Ý2¹«ŽÝ£Äƒ	Á"±Ë -êHÕ¹«Ì	Ø5"Ž±Ýb	ŽØ*å
{"±Hó  	Fà�
b­¿
&âšÖŸ6¢êµ	£"â-–}I^PÕÆ… +êäK	C©¦
ºÂÿq¿œ	Ô	
&â¾üP #Lª®Õ¾
Ÿ¿

!
ü
&4"ÁÖj…¼±O<�Øâ”áÜ`¥(½c!	]	°	šln‰ƒ™C ³3ÂÔ6[px�J@ë¡áSê$GÂ
d£¦	 µÂH‰ÇÀín˜¶»efzƒÈlmyz¡+,�ÁËdACS ’%R	 
51Š §
ôŠ@& 

QæßŸÞXAuý7
j@+´ÝƒÃ¹É	ï

‚e
�
F ¢J´³Ýƒt±�
æ!t,GÂË6¹«*l	Ì	å
Ø5={"Ž±&Hó Ý2Ul#øÌ5ó›êGd¦	ÂHz�Ëo	m$moA>cƒ �¿ä:¢µêýíÕÙµ	\
#H¦`;}ƒŸ£ÌÐ¸¯{ˆßªÏÞßGÂÇ¶»¡Ë~	ó¢ê¿µ	£’›ágr5½³züØöÇÖ0ˆ4Óï£Á»ëþ9Ý «MXbw™3F:²¨ �!	]	°	�?YšlÎäçÅŠ[·ÿˆ	† è¥bJ~	E]Ú‘Ñ¹«~	ŽTlEÝ] #mÀ"„
		„	¯	C
5#_h»óyš:yŒ–#FÉ6ÛøÌ‰((›®Ì5%¬ó}5z!2VßªŸt?Ç	 
Â
z½!»ÿÙâû %Lƒ	… K	C
ºÂznƒ‰ƒ	™CiV[ K'}¯s¼ŸÊÚµ™¯UÆ¶é
Zlšß-#5 g½5½³zØœõØös ÙDS`ÙÂÓ
”-ÌÁîo™Vkf„˜¯Èmz,Û4²‚
‹
ÃÕç"u7[p	úë,§x�‡9‡ DŒZ]žAS[¼êÁ	Y
Á
Î
êOy¢ÿ‚¼ŽË½¹¼ÁÄØ í þ M
P	!
ý
0;|"#0†¼±²ºŠà•¬S`¦( á©Á y“¶ù#£¤�	 =zµ%†AÁÂd)²Ì½ÐÙÌÈ®Ÿ í 
P	ý
0à•¦(‡ DžASêÁ	Y
Á
Î
Oy‚¼Ž¼ÄŒZ][¼ê¢ÿË½¹ÁØæ5ð× Ss#	•
žJ�7º¬^øµä‡ DŒZ]ž-È>ASÇ [¼êÁ	Y
Á
Ä
Î
_¶êõOTy¢ùüÿëKt‚×¼ßŽË…½½ì¹¼ÁÄÔ‚”yØóÁ yS`ÙÂÓ
“¶ù#£¤�	 =zµ”%-ÌÁîo™Vkf„˜¯Èmz†,AÁÂÛd�—4t‡ÙHáÅ°€ œxÄŸç~òñÉ_¼Í¶›Ê¨ Ó Iß^P¼\	ÕžÍ(œÆ7ÚóTaÕV¢Ö ‹r}Ib^6š¹˜û	ñ²T¬è
Kqˆ¢Há£
†Æ›Ì”p°®¸j)Uü“ÄýÓ¯ÒŒ lc¥Èxœ)pêÃ¢Há²T¬£
è
N^KqÞˆUb\WÔH±F�¤Åïy«ÏÌÈ`LŽ`
®¬0is>Æ	Q
V
Sºo„°
#”¯ˆªýÅß|�Xª÷}3ø	6A•šn u�a
h„ª¹9æõ^Ç
 ÈOÕ6„ÁÆU{µd	s	é
ƒïG¨}”óŠ ó3Žòr˜Ó‰/	%
0
Ù
�—IoFŸ Øô
-˜}[gbòì< v ÁÜP�M¬Y	n
‹½Ê›ËˆYuCŸöé¥moAš¦`>ÖŸcÐjp	n¥7%|X3øš�ªAv M¬Y	n
‹½›ËˆY¥÷}	6•-È>Ç Ä
_¶õTùüëKt×ß…½ìÔ‚”yóH±FUb\�¤ÅWÔï^ �4>TRóóùèÖ÷·
z8‚Ç{âä)
_
aS€ ­7~¼ëÑÓßúM £3#8?¢È@jt›?Ç	R
W
 
`·öì[uØ!T³»G©&¢Ã1zÞ 9¬¡-¬Èj{• NYcox„°
Ä
#T”ùüK¿ß¯…ˆš¦À½4GªìÔý‚;ÅÓßûN”Nó¶ Ckšf¨°VÇ¾·êB[m› X ¼ ÅÆôN0Û¨»ðØ[
Ð
{E’�z+v¤¶¾”› ø �îœ CQr^|ãÀ�	¹	Õ	
*
'Ub
Rw�Ÿ¡…ã¿ÒÓÞà Lº 	ëÖ?
ˆ
I¹$ç¸Äê5 6 H �`hs¾6 v	¾]f´{€ýÙ�´öÙÀDÓ÷þ NÊÜçî"(â	é	!
·
Æ
;}µcêÐå#0á‡¼e²»Ti‹Þ­îT`„
!â�ªõT Â '»y“&3”¶ú$¤S	�	

 6>z³ 2µRç&�Üà†BÂd/ 9 $ôH£ëWÀ{	¶	‘ê¤ÃÝ“œüù§ÌJ\Í6¿ã X b ¼ þ %NZÅâY¨ÁÆôN°ÊÜç0CÓÛèîú"(EÀ1Z‡¨»ìð+Ø;	Ã	â	é	
!
[
·
Æ
Ð
æ
î
	;}µÆÎéV_c{¡íþP|†—ê	.EUÐÖå#0’áè<W‡¼e��²?z‘»Ê+>Tiv‹¼¤¿Þ÷L^x~­îÖT`„¶¾
I«ô!Ùâ`�”ªõ/ 9 e ˆØÚÜ$:÷k´ô¥§Ë0H‹£¬ëôWÀ{	¶	‘Ñê¤ÃÝ%÷ùñv“œ:ÝübdÛùMŸ§$Öâ
Ì JL¤¬óJ\fpuz‡ÀÍ*6iF}¿ÐÝã– 6KW	h	l
€
Y†AÈ¥ìµÏ¢¶÷ syâ3†¯»„ã#( † é C’º¬â.¡ªéò¾€†L	f
‘
G¥Dóg·þ�G»Ã�‰ÞÒÊ ü=™á‰	‡K&Sd…ð"˜Í]®>‚ðüÿ$*ö`ä	ë	9
3lra´ºWŠÚB‰-yJ}¬ Û IdÉçX‹¸Ëš	ì
9ÄL± ©Öñ—Wô;ADJkÒúu©é¥ Ì ·ìúÿ3Ð	­ÄÜúj.Æ: X – ¼ ©6ÅÚ=ÆÕèô N�0ÛÒK¨»ÊðõØâèW	h	/
[
l
€
Ð
/Y¬,{†ÎAEÈ,k’¥ËÕìûiªµÏ�¢zÿ+Dv¡x¤¶†—±»ÇÓà÷þ \aNs¶¾yâ3†¯»„”Ããè#‘!	„	ƒ7[ý§`ºÉ1Ã	K?ï  <     ›          á×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–l÷_FãßcõTQHbäxDÕ-•î;�iíaK	±CáÇPW³µS€JOŸâx7!EÔÀþ;þlF8¶zãÿ�CØ5®0]sÔ¶¼â;¾íÛ1À9R6ì7óõÑÒq_àU´ìÊø‹MC®þ\Þ';‹Ï =êw€ã&�ÐMµ$ÕDù÷Æ¹�ýë„u5¡8¬}´ñ~>¾«�ym˜ƒàEtåHÅL0<°CÐƒ	2ÿ%0»¶ƒ]eÜpG�A¶¡§Tq‡CÐ”–:ªªìîÚ«UvUhAPZ*»ëÓ~ÉjÇ†
ý¤·eN$µ'G/Ì:Æ|·×ððÏ‘8PlC ±q+PÀ0`ADÁ�"u@è@@ÕOPëô-Æ$ø./cÐ…Qú¥øa°¥B<»0öñÊT(=®4M%ýrîº¹ñà¢ÎÇn¯H~PµzP	t¸?–«GVtWt´tG]ÑqŽ4Î4ÑÔs0ë
õ|TÕZÑÁâ©
ì»çÑ}Ù¾Á¯vÇ¿¯´,uWýRþË¿@£+Eì´¯}À¼ôgDä¤åä�ÐÍ—m]‘ÞG[Gte(àôéûð‚Âø »Õ¿ÿVü²K[{DþýAtÄ}Æ°cWMD:šgÒæÁGƒ3Ä„ˆêš¸é™¿|�ÏŸ?j2Ö Á(§ªKò†¨#Õu{ö‡-`è¿ÈKWÎosö†'�Uómö	dÆYÉž=IKöP¶'€ÙcÐÀö§ËhrÖ@žƒfÞ†'�RJŸ%g½ý¡ËX/æƒ)ævrÚhrÖ , 0´ô0=©òR˜—0^öf˜^XÉhiæ–^KYmb×`ÂX vÖebvi†`g\˜ÖS–ºqP>Èg>j¦B–-†Y`«¤rÐƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TI„š×jò,þšþªŒ6¨úøªŽßÑ\à…ITc…J7�±xµÓ	Fú*³üQr«ÖMê•+ŽbÂi¿"‡<D×°³Í�æ»E‡ ¡'·ÒÝMºp`Øt”E¦4Ž=—ØHeÞ0õé:        —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö¬Y¹ÀªÚl‰H*¹:D1tH¶È±ÈsSƒŠ€²�ÓdI5¤ˆLŒŠÜ”ª ÓÕ˜ÛM×¬¶™¢sáÙŒm[‹ålRUéX`J‚YºmÃÚt¥Û–+Ý¶œÈÚÜ¦Ë6¦ºØ\+ÚØÐt[´ÈÅÐœi’†F&MZddAdºXÖØ6§&s-klÑd¬–8'a.çbi2Ú ¥AnÛ ¥S H§‡›+9‰Ò(Kgé\2`  MRVe¬²ÀUmTY±Ê¢�*+«-¶ˆ%ËmÉpsérU¤«ÂmŠèjË…ƒ-bÉr[2Ü\º\éªp›"êÀ…ˆlŠ¤Åâ4ÇÌaWMV.SQS5fêÂÊ­¹œZ2Í	!×B›ÓŠ\²Ö$jÛD›L4ÀÌ(IÉ�Z«U³VSWIÕœS#U�„ª¹°M˜8‰"Ô©P ¡Íb	.!ªmlÅ«¡V†“&Ì¢peªÑ¢jk9rKR«šÛdSÕm›+Â˜ÛÆ¶1c5¡M7W›+çr2›.)´°…+Ú$l-ç¦1'kg›C«QE™Û¦BIsE²Ìm$©æ*q+sˆÐJçJg"²)2Ek”)h9ms[­T73E7‡Ó©Ž&mªjªIÎl¶¤°…À
‰Í‰£9[+$Ñ\$¬ «Qº­J²F’Ûrº™Û\å$ÊUPµjZ••“*+'UVY™ÔtZ”Z²¹ÄÜÈÄæÒÌµ9�›Næ´Òml¦(‹-bÅ–˜Ôæ´4·jE”c³W‰ !Ìr9KÓÖ¦åšdRejmnÛšº¦µÔ\R%™å˜­\)†•mºe’k9Ã¶&.È
*\¹[eÐÒ*)ætMæD·œ.�€Æ”ÉÊÅ–e¹d˜[LË¡Ke3…�™ÌÈHl8‹¤5·fLŠÅ\aÉ¤Ê™)iàÚL)'”™,5,£˜³ÙBee,]ni0&«ÀJsÛ\±É×JËUke¡9&…Œl+‡Úbl¹ r+Ë`•ÍMgËmXc¦956“Lfº9fº¹…ÑææÂlªsêTUØ†+ÒÜ
¥µ–mkŽ±6¶MQÆ–6·­„µ¨Ôt¥®¹¹…‘l:ªæ6Õ9S `	5×¬Ù‚‚¤Mç
rsB@°¹F†º-)ÉUEW†ÔÒ¹,H±51D—@Y"¨ÒRlkÑVŒ¶V@4�•s:!› T¹ X*AU¶Æ*æb®Jg-‘å6d­m4£6 Àæ(U«°Õ¶é¶ c13EPb.EY* AÐbÍ®"�&œË¹‚',hÖ˜AéÂ
pæÈU´E’uWb!+u9c©+aF,WHÉd¨¸¹T]AMVB¸Íe�`
M6ÍµœÓ9‘™a•Z2g‰š
Ò0@]Lrf›®5I(7§®L\Ãœkš¶Jqâ*—�­(&E2¡‘ Q@DˆEcs,UqsBÂ¹6C™T¤�.ÝtÛ,]�ƒÉX+] 9 e@–•ce1©•5²©ÆlP.kÎÉV‚†cP(†E8„b²[l„±0¥Ô ÁrÛ¶msæœlÛ@EÀTlm›ÓMIt6Øj¸Xm*Md@®Ñ„†„MÍr3†61H°˜––éˆ hQ¹b@E1£¬š�QÔ&TE„U+
¢(‹r£ZC r•Šªš )”›JMŒ5ªÐÕ\µ¦,+¥@ès]µXÔœµµ´9³”iØÔVÊæ’H‚¨`snn!sh¸ÚZdLs†ÌmJÔÜ ¢Õ@š+u°mCDš„D"�±\’¹$	!Ì,7kS@€MÂ¢¬ÀµmÔælN‡(2¦«f±)2Ã©›NjVŠ XªM]…Í©T[–Vk“ÀÙ¤MQ¬¦)1$r´‘GCÂ¤L2!Žf!!ƒ¶\)¹¡SkµjÖjê*©šS`ja¤*°€PµÙªÑ„‰“(B�
’Š±Y,Iˆr[Ãj¨•aÒ³ \™i´¨ÚZåÜ6¶È¹Ü#t*ÚÓ¡©lË&¬Ê¢­C¶­€¦¶Å¶ÕR@À©laVµ"Ü
˜j‹& 9¦˜Êk¸@“‰²ŒŒ…ƒa#Öp)4
h*ƒš¬á*,¥¬”mh“-lÂ¨Ê†[ÉXq‹5\
­’¶¡NQÙÂ&¬€¦Ž­lÃ±
dØdc›°Êªf[eMRÊJÙ†6hcÌ§Œ±Ê±ÀÁBµÁŽŽ&&¬	²²k+d‘Â°†Œ�ÅX1KX)ä`sÂ€Jg‹a:¶mŒÚ`MƒÁj›a“Z‰Ûf°–Y :¶µ�m›†lc�iN!ÔÅ€å&Æ ÑX46A¶ik¦nlê¶mY²mé¦kÛ–• sµ€Ë1i«–­Ú�¸bN�¬AL·ˆ¶ÍTƒÀ¶Ma±HÜ6 ÍåX+³ÆÆÔÖ¦•	Îši2Ä±9	nµEÃ‰ÒDHæ†ÅJÒ ‚�%-—2P-â²Üps!³(4(r ¹m["Èªb²Ît‹ÙV�¹`AÊPÀ0²…(ÆÒ%	+A°-plàÊÀá†sä¦– l0Â+Êb@[R(n.s–ºi¹rµ�-æŠ´Ùª9³ÆdKW¥Äj�:µ1mÌ!†U4)Á±b�#$f.bÔÒ‰‹’­®I(´'c·[lp“ml(æ¨1Ý¶Å`N
0u[´m¶).²I¨6ˆ	ss‹˜nÛ6—Ù`.—[ ŠæP²VÛÚ–"‡‚sÛ¦A\¹I™ÄP`¸¦›£5ÒF¥(nBà\#ÑtÈÐ™s9˜®¥•Ë¥´2ÍÖÜÐj+œÆhC‹A™ôœM"T   º<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220983-sequence-437500" ID="0" sortOrder="1" manuallyTrimmed="1" trimmedRange="0..7681"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  "þ<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5042-5077" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="16" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="5146" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5081-5146" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="15" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5347-5763" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5964-6163" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6226-6401" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6402-6605" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6606-6985" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4360" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="7344" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="7276-7344" color="#ccffcc" type="standard" translated="1"/><Segment range="7345-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7171-7275" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4361-4363" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="0" name="Î» N peptide" directionality="1" translationMW="149.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="4361-4363" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Ü<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:43:10">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  [<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..7682" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..7682" colors="black"/></BottomStrand></StrandColors>  <     ›          á×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–l÷_FãßcõTQHbäxDÕ-•î;�iíaK	±CáÇPW³µS€JOŸâx7!EÔÀþ;þlF8¶zãÿ�CØ5®0]sÔ¶¼â;¾íÛ1À9R6ì7óõÑÒq_àU´ìÊø‹MC®þ\Þ';‹Ï =êw€ã&�ÐMµ$ÕDù÷Æ¹�ýë„u5¡8¬}´ñ~>¾«�ym˜ƒàEtåHÅL0<°CÐƒ	2ÿ%0»¶ƒ]eÜpG�A¶¡§Tq‡CÐ”–:ª«³»j­UýÙU¡@Qhªï¯Mû%¨+ö’Ý•8’Ô�¿0ëòÜS\ÃÃ>DPH@àe@A±ÅÄ­@G Á�C:@‰Õ¡ý U=C¯Ð·�à¸½ŒBGèn—à!„.Â•òìÃÛÇ)P ö¸Ñ4P—õËºèvçÇ‚ˆLo;º½!ùBÕé@H%ÒàþZ­YÑ]ÒÑÑwEÆ8Ó8ÓGQÌÃ¬+ÕñSUkG0Š¤+²ïŸE÷føp½Ûþ¾Ð°=Õ\?õKø.ýŒ<­²Ò½÷óÑ�’“—’tsC6]µvGylÑ”£ƒÓ§ïÂ/à4ïVüOýXTòÈ	-míGûõÓ÷Á�]5êhœ	üsK›Ï
 ;ªhNã¦d~ýòw>|ý¨ËX¢œv¨/Ê �UÕïÚµ€ G Vÿ!-_9½ÏÚž=WÍ·Ø%“yg$bxõ$/ÙBØže�CÚŸ-¡ËY 2z˜gzž=H*|•ž÷ö‡-`T¿š§˜ÙËi¡ËX ²€ÂÓÐÀö§ÉJb\Á{Ù˜ayaÿ%¡§šYy-eµ‹]ƒ	b�ØOY•‰Ù¦��rcX=NZèQÅ@û!œùª™
X¶e‚®‘ËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ&k]«È³úkúª0Ú£ëâª;Es‚%QŽm(ÜH
vÅàn×L%èDªÏñEÊ¯Xa7ªT®9ˆ3	¦üŠð5^ÂÏ6wší‚„žßKtU6éÁƒaÒQ˜Ò8ö_a!—xÃ×§
        —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö¬Y¹ÀªÚl‰H*¹:D1tH¶È±ÈsSƒŠ€²�ÓdI5¤ˆLŒŠÜ”ª ÓÕ˜ÛM×¬¶™¢sáÙŒm[‹ålRUéX`J‚YºmÃÚt¥Û–+Ý¶œÈÚÜ¦Ë6¦ºØ\+ÚØÐt[´ÈÅÐœi’†F&MZddAdºXÖØ6§&s-klÑd¬–8'a.çbi2Ú ¥AnÛ ¥S H§‡›+9‰Ò(Kgé\2`  MRVe¬²ÀUmTY±Ê¢�*+«-¶ˆ%ËmÉpsérU¤«ÂmŠèjË…ƒ-bÉr[2Ü\º\éªp›"êÀ…ˆlŠ¤Åâ4ÇÌaWMV.SQS5fêÂÊ­¹œZ2Í	!×B›ÓŠ\²Ö$jÛD›L4ÀÌ(IÉ�Z«U³VSWIÕœS#U�„ª¹°M˜8‰"Ô©P ¡Íb	.!ªmlÅ«¡V†“&Ì¢peªÑ¢jk9rKR«šÛdSÕm›+Â˜ÛÆ¶1c5¡M7W›+çr2›.)´°…+Ú$l-ç¦1'kg›C«QE™Û¦BIsE²Ìm$©æ*q+sˆÐJçJg"²)2Ek”)h9ms[­T73E7‡Ó©Ž&mªjªIÎl¶¤°…À
‰Í‰£9[+$Ñ\$¬ «Qº­J²F’Ûrº™Û\å$ÊUPµjZ••“*+'UVY™ÔtZ”Z²¹ÄÜÈÄæÒÌµ9�›Næ´Òml¦(‹-bÅ–˜Ôæ´4·jE”c³W‰ !Ìr9KÓÖ¦åšdRejmnÛšº¦µÔ\R%™å˜­\)†•mºe’k9Ã¶&.È
*\¹[eÐÒ*)ætMæD·œ.�€Æ”ÉÊÅ–e¹d˜[LË¡Ke3…�™ÌÈHl8‹¤5·fLŠÅ\aÉ¤Ê™)iàÚL)'”™,5,£˜³ÙBee,]ni0&«ÀJsÛ\±É×JËUke¡9&…Œl+‡Úbl¹ r+Ë`•ÍMgËmXc¦956“Lfº9fº¹…ÑææÂlªsêTUØ†+ÒÜ
¥µ–mkŽ±6¶MQÆ–6·­„µ¨Ôt¥®¹¹…‘l:ªæ6Õ9S `	5×¬Ù‚‚¤Mç
rsB@°¹F†º-)ÉUEW†ÔÒ¹,H±51D—@Y"¨ÒRlkÑVŒ¶V@4�•s:!› T¹ X*AU¶Æ*æb®Jg-‘å6d­m4£6 Àæ(U«°Õ¶é¶ c13EPb.EY* AÐbÍ®"�&œË¹‚',hÖ˜AéÂ
pæÈU´E’uWb!+u9c©+aF,WHÉd¨¸¹T]AMVB¸Íe�`
M6ÍµœÓ9‘™a•Z2g‰š
Ò0@]Lrf›®5I(7§®L\Ãœkš¶Jqâ*—�­(&E2¡‘ Q@DˆEcs,UqsBÂ¹6C™T¤�.ÝtÛ,]�ƒÉX+] 9 e@–•ce1©•5²©ÆlP.kÎÉV‚†cP(†E8„b²[l„±0¥Ô ÁrÛ¶msæœlÛ@EÀTlm›ÓMIt6Øj¸Xm*Md@®Ñ„†„MÍr3†61H°˜––éˆ hQ¹b@E1£¬š�QÔ&TE„U+
¢(‹r£ZC r•Šªš )”›JMŒ5ªÐÕ\µ¦,+¥@ès]µXÔœµµ´9³”iØÔVÊæ’H‚¨`snn!sh¸ÚZdLs†ÌmJÔÜ ¢Õ@š+u°mCDš„D"�±\’¹$	!Ì,7kS@€MÂ¢¬ÀµmÔælN‡(2¦«f±)2Ã©›NjVŠ XªM]…Í©T[–Vk“ÀÙ¤MQ¬¦)1$r´‘GCÂ¤L2!Žf!!ƒ¶\)¹¡SkµjÖjê*©šS`ja¤*°€PµÙªÑ„‰“(B�
’Š±Y,Iˆr[Ãj¨•aÒ³ \™i´¨ÚZåÜ6¶È¹Ü#t*ÚÓ¡©lË&¬Ê¢­C¶­€¦¶Å¶ÕR@À©laVµ"Ü
˜j‹& 9¦˜Êk¸@“‰²ŒŒ…ƒa#Öp)4
h*ƒš¬á*,¥¬”mh“-lÂ¨Ê†[ÉXq‹5\
­’¶¡NQÙÂ&¬€¦Ž­lÃ±
dØdc›°Êªf[eMRÊJÙ†6hcÌ§Œ±Ê±ÀÁBµÁŽŽ&&¬	²²k+d‘Â°†Œ�ÅX1KX)ä`sÂ€Jg‹a:¶mŒÚ`MƒÁj›a“Z‰Ûf°–Y :¶µ�m›†lc�iN!ÔÅ€å&Æ ÑX46A¶ik¦nlê¶mY²mé¦kÛ–• sµ€Ë1i«–­Ú�¸bN�¬AL·ˆ¶ÍTƒÀ¶Ma±HÜ6 ÍåX+³ÆÆÔÖ¦•	Îši2Ä±9	nµEÃ‰ÒDHæ†ÅJÒ ‚�%-—2P-â²Üps!³(4(r ¹m["Èªb²Ît‹ÙV�¹`AÊPÀ0²…(ÆÒ%	+A°-plàÊÀá†sä¦– l0Â+Êb@[R(n.s–ºi¹rµ�-æŠ´Ùª9³ÆdKW¥Äj�:µ1mÌ!†U4)Á±b�#$f.bÔÒ‰‹’­®I(´'c·[lp“ml(æ¨1Ý¶Å`N
0u[´m¶).²I¨6ˆ	ss‹˜nÛ6—Ù`.—[ ŠæP²VÛÚ–"‡‚sÛ¦A\¹I™ÄP`¸¦›£5ÒF¥(nBà\#ÑtÈÐ™s9˜®¥•Ë¥´2ÍÖÜÐj+œÆhC‹A™ôœM"T   º<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220983-sequence-437500" ID="0" sortOrder="1" manuallyTrimmed="1" trimmedRange="0..7681"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  "þ<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5042-5077" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="16" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="5146" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5081-5146" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="15" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5346-5762" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5963-6162" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6225-6400" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6401-6604" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6605-6984" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4360" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="7343" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="7275-7343" color="#ccffcc" type="standard" translated="1"/><Segment range="7344-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7170-7274" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4361-4363" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="0" name="Î» N peptide" directionality="1" translationMW="149.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="4361-4363" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Û<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:43:5">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  [<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..7681" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..7681" colors="black"/></BottomStrand></StrandColors>  ;>     š            á×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–l÷_FãßcõTQHbäxDÕ-•î;�iíaK	±CáÇPW³µS€JOŸâx7!EÔÀþ;þlF8¶zãÿ�CØ5®0]sÔ¶¼â;¾íÛ1À9R6ì7óõÑÒq_àU´ìÊø‹MC®þ\Þ';‹Ï =êw€ã&�ÐMµ$ÕDù÷Æ¹�ýë„u5¡8¬}´ñ~>¾«�ym˜ƒàEtåHÅL0<°CÐƒ	2ÿ%0»¶ƒ]eÜpG�A¶¡§Tq‡M	Icªª»;¶ªÕ_Ý•ZTŠ®úôß²Z‡ñá‚¿i-ÙS‰-IÑËó±Ÿ-Å5Á¼<3äE„TÀ,\A
Ô DpQ0C¤�P:Ð µSÔ:ýq‰ ~€‹ØÀô!T~†é~Bì)P�.Ì=¼r•
k�E	\»®‡n|x(„Æó±Û«Ò”-^”‚].åªÑÕ�Ý-×t\c�3�4uÌ:Â½_5V´pCxªB».ùô_vo‡ °kÝ±ïëíÝUÃÿT¿€rïÐ(ÃÀŠÑ{-+ßp/=Ñ9)9y'G43eÛWdw‘ÖÁÑÝJ8=:~ü €°‚þ@.õoÁÄÿÕ…Gÿ,€’ÖÞÑ¿P]1q¬ÕÓQ¦€YÀŸÀÇ4¹°QàÌñ! ¢º¦„î:fGïß'sçÏÚŒµ€0J)Çj�Rü¡ªõ]^ý¡ËXzoòÕó›Üý¡‰ãÕ|Û}‚Y1‡–rF'�RARý”-‰à6Xô0=©òÚµ�' Ù†w¡‰ãÔ€Ò§ÉYïhrÖKù Êy€]œ¶šµ€À(-=j|”¦%Ì½™€æ–òZy¥—’Ö[XµØ0–(„õ™X�ša˜×&5ƒÔå®…T²Ïš©�¥‹a–X*é´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡Ua&µÚ¼‹?¦¿ª£ª>¾*£·ôW8!RUáFÒ€�Ä€§l^ítÂQ¾„J¬ÿ\ªõ†z¥Jã˜ƒ0šoÈ¡ÏQ5ì,ógy®Ñaè(Iíô·ESnœ6%i�#�eöwŒ=zz      ÿ  —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö¬Y¹ÀªÚl‰H*¹:D1tH¶È±ÈsSƒŠ€²�ÓdI5¤ˆLŒŠÜ”ª ÓÕ˜ÛM×¬¶™¢sáÙŒm[‹ålRUéX`J‚YºmÃÚt¥Û–+Ý¶œÈÚÜ¦Ë6¦ºØ\+ÚØÐt[´ÈÅÐœi’†F&MZddAdºXÖØ6§&s-klÑd¬–8'a.çbi2Ú ¥AnÛ ¥S H§‡›+9‰Ò(Kgé\2`  MRVe¬²ÀUmTY±Ê¢�*+«-¶ˆ%ËmÉpsérU¤«ÂmŠèjË…ƒ-bÉr[2Ü\º\éªp›"êÀ…ˆlŠ¤Åâ4ÇÌaWMV.SQS5fêÂÊ­¹œZ2Í	!×B›ÓŠ\²Ö$jÛD›L4ÀÌ(IÉ�Z«U³VSWIÕœS#U�„ª¹°M˜8‰"Ô©P ¡Íb	.!ªmlÅ«¡V†“&Ì¢peªÑ¢jk9rKR«šÛdSÕm›+Â˜ÛÆ¶1c5¡M7W›+çr2›.)´°…+Ú$l-ç¦1'kg›C«QE™Û¦BIsE²Ìm$©æ*q+sˆÐJçJg"²)2Ek”)h9ms[­T73E7‡Ó©Ž&mªjªIÎl¶¤°…À
‰Í‰£9[+$Ñ\$¬ «Qº­J²F’Ûrº™Û\å$ÊUPµjZ••“*+'UVY™ÔtZ”Z²¹ÄÜÈÄæÒÌµ9�›Næ´Òml¦(‹-bÅ–˜Ôæ´4·jE”c³W‰ !Ìr9KÓÖ¦åšdRejmnÛšº¦µÔ\R%™å˜­\)†•mºe’k9Ã¶&.È
*\¹[eÐÒ*)ætMæD·œ.�€Æ”ÉÊÅ–e¹d˜[LË¡Ke3…�™ÌÈHl8‹¤5·fLŠÅ\aÉ¤Ê™)iàÚL)'”™,5,£˜³ÙBee,]ni0&«ÀJsÛ\±É×JËUke¡9&…Œl+‡Úbl¹ r+Ë`•ÍMgËmXc¦956“Lfº9fº¹…ÑææÂlªsêTUØ†+ÒÜ
¥µ–mkŽ±6¶MQÆ–6·­„µ¨Ôt¥®¹¹…‘l:ªæ6Õ9S `	5×¬Ù‚‚¤Mç
rsB@°¹F†º-)ÉUEW†ÔÒ¹,H±51D—@Y"¨ÒRlkÑVŒ¶V@4�•s:!› T¹ X*AU¶Æ*æb®Jg-‘å6d­m4£6 Àæ(U«°Õ¶é¶ c13EPb.EY* AÐbÍ®"�&œË¹‚',hÖ˜AéÂ
pæÈU´E’uWb!+u9c©+aF,WHÉd¨¸¹T]AMVB¸Íe�`
M6ÍµœÓ9‘™a•Z2g‰š
Ò0@]Lrf›®5I(7§®L\Ãœkš¶Jqâ*—�­(&E2¡‘ Q@DˆEcs,UqsBÂ¹6C™T¤�.ÝtÛ,]�ƒÉX+] 9 e@–•ce1©•5²©ÆlP.kÎÉV‚†cP(†E8„b²[l„±0¥Ô ÁrÛ¶msæœlÛ@EÀTlm›ÓMIt6Øj¸Xm*Md@®Ñ„†„MÍr3†61H°˜––éˆ hQ¹b@E1£¬š�QÔ&TE„U+
¢(‹r£ZC r•Šªš )”›JMŒ5ªÐÕ\µ¦,+¥@ès]µXÔœµµ´9³”iØÔVÊæ’H‚¨`snn!sh¸ÚZdLs†ÌmJÔÜ ¢Õ@š+u°mCDš„D"�±\’¹$	!Ì,7kS@€MÂ¢¬ÀµmÔælN‡(2¦«f±)2Ã©›NjVŠ XªM]…Í©T[–Vk“ÀÙ¤MQ¬¦)1$r´‘GCÂ¤L2!Žf!!ƒ¶\)¹¡SkµjÖjê*©šS`ja¤*°€PµÙªÑ„‰“(B�
’Š±Y,Iˆr[Ãj¨•aÒ³ \™i´¨ÚZåÜ6¶È¹Ü#t*ÚÓ¡©lË&¬Ê¢­C¶­€¦¶Å¶ÕR@À©laVµ"Ü
˜j‹& 9¦˜Êk¸@“‰²ŒŒ…ƒa#Öp)4
h*ƒš¬á*,¥¬”mh“-lÂ¨Ê†[ÉXq‹5\
­’¶¡NQÙÂ&¬€¦Ž­lÃ±
dØdc›°Êªf[eMRÊJÙ†6hcÌ§Œ±Ê±ÀÁBµÁŽŽ&&¬	²²k+d‘Â°†Œ�ÅX1KX)ä`sÂ€Jg‹a:¶mŒÚ`MƒÁj›a“Z‰Ûf°–Y :¶µ�m›†lc�iN!ÔÅ€å&Æ ÑX46A¶ik¦nlê¶mY²mé¦kÛ–• sµ€Ë1i«–­Ú�¸bN�¬AL·ˆ¶ÍTƒÀ¶Ma±HÜ6 ÍåX+³ÆÆÔÖ¦•	Îši2Ä±9	nµEÃ‰ÒDHæ†ÅJÒ ‚�%-—2P-â²Üps!³(4(r ¹m["Èªb²Ît‹ÙV�¹`AÊPÀ0²…(ÆÒ%	+A°-plàÊÀá†sä¦– l0Â+Êb@[R(n.s–ºi¹rµ�-æŠ´Ùª9³ÆdKW¥Äj�:µ1mÌ!†U4)Á±b�#$f.bÔÒ‰‹’­®I(´'c·[lp“ml(æ¨1Ý¶Å`N
0u[´m¶).²I¨6ˆ	ss‹˜nÛ6—Ù`.—[ ŠæP²VÛÚ–"‡‚sÛ¦A\¹I™ÄP`¸¦›£5ÒF¥(nBà\#ÑtÈÐ™s9˜®¥•Ë¥´2ÍÖÜÐj+œÆhC‹A™ôœM"T   º<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220983-sequence-437500" ID="0" sortOrder="1" manuallyTrimmed="1" trimmedRange="0..7681"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  "þ<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="17" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5206" maxFusedRunOn="5206" detectionMode="exactProteinMatch"><Segment range="5042-5077" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="16" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="5146" consecutiveTranslationNumbering="1" maxRunOn="5206" maxFusedRunOn="5206" detectionMode="exactProteinMatch"><Segment range="5081-5146" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="15" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5344-5760" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5961-6160" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6223-6398" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6399-6602" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6603-6982" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4360" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="7341" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="7273-7341" color="#ccffcc" type="standard" translated="1"/><Segment range="7342-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7168-7272" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4361-4363" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="0" name="Î» N peptide" directionality="1" translationMW="149.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5206" maxFusedRunOn="5206" detectionMode="exactProteinMatch"><Segment range="4361-4363" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Ü<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:42:58">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  •<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..7679" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..7679" colors="black"/></BottomStrand></StrandColors>  >Û     ›          á×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–l÷_FãßcõTQHbäxDÕ-•î;�iíaK	±CáÇPW³µS€JOŸâx7!EÔÀþ;þlF8¶zãÿ�CØ5®0]sÔ¶¼â;¾íÛ1À9R6ì7óõÑÒq_àU´ìÊø‹MC®þ\Þ';‹Ï =êw€ã&�ÐMµ$ÕDù÷Æ¹�ýë„u5¡8¬}´ñ~>¾«�ym˜ƒàEtåHÅL0<°CÐƒ	2ÿ%0»¶ƒ]eÜpG�A¶¡§Tq‡M	Icªª®ÎíªµW÷eV„E¢«¾½7ì–¡üx`¯ÚKvTâKRtrüÃ¬gËqMpoùA!�•Ä0Bµ Aé'T‡ô -Tõ¿BÜb@‚à"ö0=U¡º_€†»
T#Ë³o¥BƒÚãDÑB_×.ë¡ÛŸ
!1¼ìvêô‡åW¥ —Kƒùj´ugEwKGDuÝãLãMG3°¯WÅMU­À^*�®Ë¾}Ý›áÀ,÷l{úûBÀ÷UpÿÕ/à»ô
0ð"´^ËJ÷ÜÏFtNJN^IÑÍÙvÕÙäu°twFRŽNŸ¿ , ¿€Ð½[ðq?õaQÿË $µ·´AïÔLGÜk5tÔC© p'ð1Í.lx3<H@(€î©¡;Ž™‘û÷ÉÜùóö£-`ŠqÚ T¿(j‚=WW¿hrÖ ��[ü„µ|æ÷?hbxõ_6ß`–Laåœ‘‰ãÔ�T¿ebx–=j|¶‡-d Éè6a�èbxõ 4©òV{ßÚµ�Rþh2ž`g-¦‡-`0ÊOCÚŸ%)‰sïf`9…å‡ü–†žieäµ–Ö-v%Ša=fV'f˜fuÉ�`õ9k¡Gì†sæªd)bØe–
ºG-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD˜I­v¯"Ïé¯ê¨Ãj�¯Š¨íýÎT•F8Q´ #q )Û�»]0”o¡«?Å*½a„Þ©R¸æ Ì&›ò(sÀÔM{<ÙÞk´Xz
{}-ÑTÛ§‡IDZcHãÙ}„†]ã^ž         —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö\Æ,
ŠhnÛ–²ª˜¬�3Ýb¶U E.X�20Œl!Š±tIÂJlË¸2p¸á¹©%ŒpÅŠ²Ð–Š›Ëœ¥nZ®\mcËÅ€¹"­E¶jÎ¬1Ù’ÄU)±¤NmÌFsˆaMJp¬X`À‰™‹µtâbƒd«�k
mÃÉÃmÄÛ ÜdÛÛ Š9jAL·m1˜“…LÝÀm›mŠ‹lª� bÅÜÜ"¦Û¶Íe6˜Ëå–€ €¢9”¬Õ¶¶¥Å„È¡àÜ¶iPWn’D&1®éæh�´ÑF)Š›8×H42tæ\¦kCiår)­ŒA³57´Ú
'„1ÚÐbP&Y³r�UµÙ‘Tr+20tˆ.bè�l‘c�)æ¦e!5¦5È’jH™¹)U¦«1·1š®Ym3EçÂ-²Û¶ËÙ¤ª,Ò±À”³tÛ†µéJ·-Wºm9‘µ¹M—mLu±¹V´±¡é¶h‘‹¡9Ó$�L2š´È(È‚Èt±¬±mN7LæZÖØ&¢ÉX-qNÂ\ÎÅÒd´AJƒÜ¶%@:J§ �N'7W0r¥Q–ÎÒ¹dÀ  6š¤¬Ê"Xe�«,Ú¨²b•EUV8V[.lK–Û’áæÒåªHW…ÛÑÕ–[Ä’å¶d¸¹t¹*ÒUá6EÔ�ÙI‹9ÄiŽ™Ã®š¬\¦¢¦ j.ÌÔ…•[s9µdšB®…6§¹d­IÔ¶‰6™h€™Q’’:µV«f­¦®’ª95¦FªUsa5š0qE¨S¡@2BšÅ\BTÛØŠ!VC­'M˜EáÊT£EÕÖrä–:¤V5·É¦ªÛ6W„0·�mcÆjB›n®6WÎåd6]RhaW´IØZÎMcNÖÎ6‡V£Š2·M…’æŠd™ÛHRÍUâVæ¡•Î•ÎDdSdŠÖ(SÐrÚæ¶Z©nfŠn§SM
ÚTÕT“œÙlIa�4›Gs¶$VH¢¹HXAV£t[•d)Œ$·åt3·¹ÊI”« jÕ´*+'UVNª¬²25¨é´(µds‰¹	�‰Í¥™ks:7�Ìi¥Û,ØLQ[ ÄŠ-1©ÍiinÕŠ(Çf9®AB˜år.–¦­MË5É¤ÊÔÚÜ¶5!4tMk©¸¤0J2Ë1[¹R+ÛtË$×r†mM\�T¸r9¶Ê ¥URÌéšÌ‰n9]�)“•‹%,ËrÉ0·˜–C—Êf(
 3™‘‘Øp+HknÍ˜‹¹Â ’I•3SÒÀµ™RN(3YjXF1g³…ÊÊXºÜÒ`LV+€•æ¶¹b“®•–«ÖÊBsL
ÙVµÅØrAäV–Á*š›Î–Û°ÆLsjl&™ÌtsÌts£ÍÍ…ÙTçÔ©ª:°W¤¹Jk-ÛÖcml›¢Œ-mn[	kQ©èJ]ss#ÙtTÍmªs¦@Áj®-X³I›Îäæ„€`s�u[R’ªŠ®©¥sY
�bkbˆ.�²DP¥¥ØÖ¢­m­€h+çtB66A¨rA±T‚ªl�UÌÅ\•ÎZ"ËmÈZÛhFm €ÍQª(Va«mÓm Æb0fŠ Ä\Š²T ‚( Åš#\!DM8—sNXÐ¬1ƒÒ…!àÌ	�«h‹$ê®ÄBVêrÆRWÂŒX®�’ÉPqs©º‚2š¬„p›ËÁšlšk9§s"3Ã*´dÎ5$¤a€º˜äÌ6]k’PnN]˜¸†9×4m•â6ÄU.[QLŠdB#¢€ˆŠÆæXªâæ"„„-rm†2©H]ºé¶Yº“±Vº"@r@Ë€,+-Æ,ÊbR+kdS�Ù \Öœ“­)Ç P‹pÅd1¶Øca’4XnÛ¶Í™s²m  [PA°µmN7%ÑÙ`[¨ábµ©l4‘¹F65ËÍÚÄ ÁbZZ¦#‚¢EåŠÅŒ²jFQ›PVY¬(ˆ¢,Ê�j�Ê-T*ªj¤Pn*51Ö¨BWsÕš²¬”Z ¡[ÌtÕbQsÖÔÒæÌR¦aP[)›K"	j ‚Í¹¹…Ì¡ájk‘1Í2·)-tPpƒŠVi®ÔÁ¶I	i!ˆÆrIæ’$„0³Ü¬MH 6	‹²×¶Q›³9J È˜.¬šÅ¦È§n:©Y)`©
4u6§RmYZ­Mg“6E±š¦Ä�ÈÑF	“2Èd„8B˜…„HÚr¥ä†N­ÕªY«©«¤jN�©…‘ªÀBÕf«F&N¢u*HF(Æf±$!Êml«¡V†IsÌ‚pe¦Ñ¢jk•sÛØ"çrcŒÐ©hCL‡¦²-›°*‹¶6Ù¶šÚÛVKœÊ6aU+Â­€©¶hšcŠ©l±†K4™(«ÁÈX86b—B£€¦2¨É®’ÁRÊJÙ†6ÙÂ&Œªl¸•ŒÅ·XÃ¥Ð*iÚ€á•-lÂ
hêØÊ6«@†M6¶°	«¬j¶UÖ$¥¬”mhƒ6ÖÀ,pÊ«,Tl±áØ`àhÂ`Âš +k°¶B)ŒkÈØXŒC°±„•B6· ¨t¶¦cÛÆ¨Öd1¬¶¹6©•¸mVk™ªc[ÛØ¶9`È&0Ö˜ædÂ@]XnÂ`lP�Ecd›¶fêÆ¦nÛ–%Û–nº¶m9Q	0Wh ±\“¶j‰Ñª™�+æÉÄt‹hÛL5lÛ‹ÄmÚ\Žµ2klLmmaZ	‘à¬™&C›“`áV[4œ(M$€dnX¬d!"ØXÒr)eÑb .KÁ·9b!w  ù     ð®ZTR

BASE      Ú1  xÁ11 ÄÀ§]!`¹0�å¯Ÿù�wï¹ï½ïû¾ó�ïÝsß½÷Ý{îùÞ=ç¾wîý¾s¿÷îýÎ÷Þ=ï¾sÞûÞ÷½wï9ï½û}ß{ï½{î{ïÞó¾÷î}ï;ï}ï;ç~ßûÎ=ß¹ïÞ÷¾sÎ}ï½÷Þ÷Þ÷�÷Þwî}÷}÷Ýsï9ï�û½wï;ßýÞ¹_Š²æW‘@“Îå\Á†4kÌ ta8sä*Ú"I‡º†+±��•ºœ±Ô•0#–+¤d2TÜ\ª® Œ&+!Üæ²@0…&›æZÎéœÈÌ°Ê-™³DM‰ i ® &9³M×š$”›SW&®aÎ5M[¥¸q•ËÆV“"™ÐH€( "D‡¢±9–ª¸¹!a‹\›¡L*Ò@—nºm–®ÀÁd¬•®�Ð2 ËJKÃÔ-Œm7B–SIc©[nÝb,—.æÜÂØ¶Ð-d9ÕjàF”n![Žl æb’Îp-Ým))smmKuª¶tÓ-ÔÔRœŠkºMX°%3Ùš‹F­ÉæØ\U­jURHBU[!Œ¤d¹*–µÊ9Vn.$‰˜Ò6f,JÝfsg´§ŽI‹��5£m8uLZŒèf�   †      }®ZTR

BASE       g  xÁA  „°Y%<Î þ³öl6·Ì¤6A6F°¡8Ü†°‘4¢F!0G0Ù‚Íªª2g&U	€Š@�ØƒZ•i)ÍÕP‡�¶R)–HÀl±„…—:7ë/=kç  ¼<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220981-sequence-437540" ID="0" sortOrder="1" trimmedRange="0..7679"/><Sequence name="pEF1a-tTA-Advanced-TRE-miR-30a loop-Neo  (1140 .. 2467)" ID="1" sortOrder="3" manuallyTrimmed="1" trimmedRange="0..1327"/><Sequence name="ORFtag_LambdaN-SD_Frame1 - å‰¯æœ¬ - å‰¯æœ¬  (5049 .. 5314)" ID="2" sortOrder="4" manuallyTrimmed="1" trimmedRange="0..265"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  #<?xml version="1.0"?><Features recycledIDs="18" nextValidID="19"><Feature recentID="17" name="Î» N peptide" directionality="1" translationMW="149.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5200" maxFusedRunOn="5200" detectionMode="exactProteinMatch"><Segment range="4361-4363" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4361-4363" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="16" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7169-7273" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="7342" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="7274-7342" color="#ccffcc" type="standard" translated="1"/><Segment range="7343-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4360" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="11" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6604-6983" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6400-6603" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6224-6399" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5962-6161" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5345-5761" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="5146" consecutiveTranslationNumbering="1" maxRunOn="5200" maxFusedRunOn="5200" detectionMode="exactProteinMatch"><Segment range="5081-5146" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5200" maxFusedRunOn="5200" detectionMode="exactProteinMatch"><Segment range="5042-5077" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Ü<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:14:42">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  •<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..7680" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..7680" colors="black"/></BottomStrand></StrandColors>  7X       Ö        Öá×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿùržó YCÂ#*.f)ª÷Ù£Ëªb?~âë¡ÄÚù º¿îÏT5Š,…4¯¸ë¡GW\¸“ê44Áýø1Ð�¸ÃÕOr&Q�øÕ7_ô�rˆJJ TKVïµ2k]@8PcôPŸö‰€n€>Â7c©ØŠ’Ä)U\¹ÿÜÈ*¾¡UÜa–l÷_Fãß`suwr,Î]NÖN5p�»ïS¡ƒ†lÁ´ ÂL¿ÆÉCŒ.í ×AÇ™A÷çPm†hiÕaÆSBRXêª«³»j­UýÙU¡@Qhªï¯Mû%¨+ö’Ý•8’Ô�¿0ëòÜS\ÃÃ>DPH@àe@A±ÅÄ­@G Á�C:@‰Õ¡ý U=C¯Ð·�à¸½ŒBGèn—à!„.Â•òìÃÛÇ)P ö¸Ñ4P—õËºèvçÇ‚ˆLo;º½!ùBÕé@H%ÒàþZ­YÑ]ÒÑÑwEÆ8Ó8ÓGQÌÃ¬+ÕñSUkG0Š¤+²ïŸE÷føp½Ûþ¾Ð°=Õ\?õKø.ýŒ<­²Ò½÷óÑ�’“—’tsC6]µvGylÑ”£ƒÓ§ïÂ/à4ïVüOýXTòÈ	-míGûõÓ÷Á�]5êhœ	üsK›Ï
 ;ªhNã¦d~ýòw>|ý¨ËX¢œv¨/Ê �UÕïÚµ€ G Vÿ!-_9½ÏÚž=WÍ·Ø%“yg$bxõ$/ÙBØže�CÚŸ-¡ËY 2z˜gzž=H*|•ž÷ö‡-`T¿š§˜ÙËi¡ËX ²€ÂÓÐÀö§ÉJb\Á{Ù˜ayaÿ%¡§šYy-eµ‹]ƒ	b�ØOY•‰Ù¦��rcX=NZèQÅ@û!œùª™
X¶e‚®‘ËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ&k]«È³úkúª0Ú£ëâª;Es‚%QŽm(ÜH
vÅàn×L%èDªÏñEÊ¯Xa7ªT®9ˆ3	¦üŠð5^ÂÏ6wší‚„žßKtU6éÁƒaÒQ˜Ò8ö_a!—xÃ×§
      Õ  —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö\Æ,
ŠhnÛ–²ª˜¬�3Ýb¶U E.X�20Œl!Š±tIÂJlË¸2p¸á¹©%ŒpÅŠ²Ð–Š›Ëœ¥nZ®\mcËÅ€¹"­E¶jÎ¬1Ù’ÄU)±¤NmÌFsˆaMJp¬X`À‰™‹µtâbƒd«�k
mÃÉÃmÄÛ ÜdÛÛ Š9jAL·m1˜“…LÝÀm›mŠ‹lª� bÅÜÜ"¦Û¶Íe6˜Ëå–€ €¢9”¬Õ¶¶¥Å„È¡àÜ¶iPWn’D&1®éæh�´ÑF)Š›8×H42tæ\¦kCiår)­ŒA³57´Ú
'„1ÚÐbP&Y³r�UµÙ‘Tr+20tˆ.bè�l‘c�)æ¦e!5¦5È’jH™¹)U¦«1·1š®Ym3EçÂ-²Û¶ËÙ¤ª,Ò±À”³tÛ†µéJ·-Wºm9‘µ¹M—mLu±¹V´±¡é¶h‘‹¡9Ó$�L2š´È(È‚Èt±¬±mN7LæZÖØ&¢ÉX-qNÂ\ÎÅÒd´AJƒÜ¶%@:J§ �N'7W0r¥Q–ÎÒ¹dÀ  6š¤¬Ê"Xe�«,Ú¨²b•EUV8V[.lK–Û’áæÒåªHW…ÛÑÕ–[Ä’å¶d¸¹t¹*ÒUá6EÔ�ÙI‹9ÄiŽ™Ã®š¬\¦¢¦ j.ÌÔ…•[s9µdšB®…6§¹d­IÔ¶‰6™h€™Q’’:µV«f­¦®’ª95¦FªUsa5š0qE¨S¡@2BšÅ\BTÛØŠ!VC­'M˜EáÊT£EÕÖrä–:¤V5·É¦ªÛ6W„0·�mcÆjB›n®6WÎåd6]RhaW´IØZÎMcNÖÎ6‡V£Š2·M…’æŠd™ÛHRÍUâVæ¡•Î•ÎDdSdŠÖ(SÐrÚæ¶Z©nfŠn§SM
ÚTÕT“œÙlIa�4›Gs¶$VH¢¹HXAV£t[•d)Œ$·åt3·¹ÊI”« jÕ´*+'UVNª¬²25¨é´(µds‰¹	�‰Í¥™ks:7�Ìi¥Û,ØLQ[ ÄŠ-1©ÍiinÕŠ(Çf9®AB˜år.–¦­MË5É¤ÊÔÚÜ¶5!4tMk©¸¤0J2Ë1[¹R+ÛtË$×r†mM\�T¸r9¶Ê ¥URÌéšÌ‰n9]�)“•‹%,ËrÉ0·˜–C—Êf(
 3™‘‘Øp+HknÍ˜‹¹Â ’I•3SÒÀµ™RN(3YjXF1g³…ÊÊXºÜÒ`LV+€•æ¶¹b“®•–«ÖÊBsL
ÙVµÅØrAäV–Á*š›Î–Û°ÆLsjl&™ÌtsÌts£ÍÍ…ÙTçÔ©ª:°W¤¹Jk-ÛÖcml›¢Œ-mn[	kQ©èJ]ss#ÙtTÍmªs¦@Áj®-X³I›Îäæ„€`s�u[R’ªŠ®©¥sY
�bkbˆ.�²DP¥¥ØÖ¢­m­€h+çtB66A¨rA±T‚ªl�UÌÅ\•ÎZ"ËmÈZÛhFm €ÍQª(Va«mÓm Æb0fŠ Ä\Š²T ‚( Åš#\!DM8—sNXÐ¬1ƒÒ…!àÌ	�«h‹$ê®ÄBVêrÆRWÂŒX®�’ÉPqs©º‚2š¬„p›ËÁšlšk9§s"3Ã*´dÎ5$¤a€º˜äÌ6]k’PnN]˜¸†9×4m•â6ÄU.[QLŠdB#¢€ˆŠÆæXªâæ"„„-rm†2©H]ºé¶Yº“±Vº"@r@Ë€,+-Æ,ÊbR+kdS�Ù \Öœ“­)Ç P‹pÅd1¶Øca’4XnÛ¶Í™s²m  [PA°µmN7%ÑÙ`[¨ábµ©l4‘¹F65ËÍÚÄ ÁbZZ¦#‚¢EåŠÅŒ²jFQ›PVY¬(ˆ¢,Ê�j�Ê-T*ªj¤Pn*51Ö¨BWsÕš²¬”Z ¡[ÌtÕbQsÖÔÒæÌR¦aP[)›K"	j ‚Í¹¹…Ì¡ájk‘1Í2·)-tPpƒŠVi®ÔÁ¶I	i!ˆÆrIæ’$„0³Ü¬MH 6	‹²×¶Q›³9J È˜.¬šÅ¦È§n:©Y)`©
4u6§RmYZ­Mg“6E±š¦Ä�ÈÑF	“2Èd„8B˜…„HÚr¥ä†N­ÕªY«©«¤jN�©…‘ªÀBÕf«F&N¢u*HF(Æf±$!Êml«¡V†IsÌ‚pe¦Ñ¢jk•sÛØ"çrcŒÐ©hCL‡¦²-›°*‹¶6Ù¶šÚÛVKœÊ6aU+Â­€©¶hšcŠ©l±†K4™(«ÁÈX86b—B£€¦2¨É®’ÁRÊJÙ†6ÙÂ&Œªl¸•ŒÅ·XÃ¥Ð*iÚ€á•-lÂ
hêØÊ6«@†M6¶°	«¬j¶UÖ$¥¬”mhƒ6ÖÀ,pÊ«,Tl±áØ`àhÂ`Âš +k°¶B)ŒkÈØXŒC°±„•B6· ¨t¶¦cÛÆ¨Öd1¬¶¹6©•¸mVk™ªc[ÛØ¶9`È&0Ö˜ædÂ@]XnÂ`lP�Ecd›¶fêÆ¦nÛ–%Û–nº¶m9Q	0Wh ±\“¶j‰Ñª™�+æÉÄt‹hÛL5lÛ‹ÄmÚ\Žµ2klLmmaZ	‘à¬™&C›“`áV[4œ(M$€dnX¬d!"ØXÒr)eÑb .KÁ·9b!w   ¦<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220981-sequence-437540" ID="0" sortOrder="1" trimmedRange="0..7679"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
   Ü<?xml version="1.0"?><Features nextValidID="17"><Feature recentID="16" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6614-6718" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="6787" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="6719-6787" color="#ccffcc" type="standard" translated="1"/><Segment range="6788-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4364" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="11" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6049-6428" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5845-6048" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5669-5844" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5407-5606" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4790-5206" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="4591" consecutiveTranslationNumbering="1" maxRunOn="4645" maxFusedRunOn="4645" detectionMode="exactProteinMatch"><Segment range="4526-4591" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="4645" maxFusedRunOn="4645" detectionMode="exactProteinMatch"><Segment range="4487-4522" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Î» N peptide" directionality="1" translationMW="2701.03" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="4645" maxFusedRunOn="4645" detectionMode="exactProteinMatch"><Segment range="4361-4426" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Ü<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:11:16">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  o<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..7125" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..7125" colors="black"/></BottomStrand></StrandColors>  7W        ×        ×á×—Îª�×`¶%ìú(ðNö}\q2÷øÓX5×(Í^ix1yéîN¿u¥‘à`CT£A÷®3°þ¼88*há•¸Â .Ì&Ú4Þ ô`”þü›$¦çqÀÐ×˜\VGFÎ��·†”Ú	x´}JžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ï¨HNó³Í<\|LÓÒS>Âj»éÍ¸Œ&­ß6`�îÒu¸îód¥=%:¨ÕO�ûÕTûíç®“´CÄ0û¸ÙYUV’ÓØX€Á) À`0J@0`£‡–„cc¨Ùë�Ž O€¯wà£‡–„cc¨Ùë�Ž O€¯wùxwv½ÓÁ¹Þó›9Èx`ã?Ç=wó‡3øp:.;ðÛÎ�N!òï8Ø‹D*·Ëmñ\ÌCONŸ¿ , ¿€Ð¿ðq?õaQÿÎ	-míGûõÓ÷RÁ�xÔ@© gp'ð1í-lx3üH@(ŽN�WçB º¶¿þªàG••n©ªl`µ+ë‚¸;ŽÛ/�ÁÈx´r#ºñ»b—±¹ð$ê¿PÒàMŒêM?Îzçu ûƒìÝÚ÷o|$3×Ã¼® ƒþ³=úç¾ÿ’ÐR¿ÿ?Í;2ÈÐrX“ríä»#FMó„Ö0$> 0õ“N£¾³«€íàð´´ ÀÏÅï?®7:ÕLÜ¸ó8®û¯¶ïêÁk=öQ�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�Ó0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÌØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸s/û¿¿ÿþ\§ƒÅ<èPðˆÊ‹™Šj½öhòêƒX„Á_ƒøºèq6¾@.¯û³Õ�Bâ…‹!AM+î:èQÕ×.$Çú�0_ÿ~t#î0õSÜ‰”g~5C×ý#Ü¢�’ˆÕƒ»íLš×Pý'ý¢`†à°�Øêv"¤±
UW.CÿÅ÷ r
¯¨Uwe›=×Ñ¸÷ØÝ]Ç„Ë3„WSµ�S�\ nûÔè`á›0m0“/ñ²Pã»h5ÐqæP}ÇyÔašuGq”Ð”–:ªªìîÚ«UvUhAPZ*»ëÓ~ÉjÇ†
ý¤·eN$µ'G/Ì:Æ|·×ððÏ‘8PlC ±q+PÀ0`ADÁ�"u@è@@ÕOPëô-Æ$ø./cÐ…Qú¥øa°¥B<»0öñÊT(=®4M%ýrîº¹ñà¢ÎÇn¯H~PµzP	t¸?–«GVtWt´tG]ÑqŽ4Î4ÑÔs0ë
õ|TÕZÑÁâ©
ì»çÑ}Ù¾Á¯vÇ¿¯´,uWýRþË¿@£+Eì´¯}À¼ôgDä¤åä�ÐÍ—m]‘ÞG[Gte(àôéûð‚Âø »Õ¿ÿVü²K[{DþýAtÄ}Æ°cWMD:šgÒæÁGƒ3Ä„ˆêš¸é™¿|�ÏŸ?j2Ö Á(§ªKò†¨#Õu{ö‡-`è¿ÈKWÎosö†'�Uómö	dÆYÉž=IKöP¶'€ÙcÐÀö§ËhrÖ@žƒfÞ†'�RJŸ%g½ý¡ËX/æƒ)ævrÚhrÖ , 0´ô0=©òR˜—0^öf˜^XÉhiæ–^KYmb×`ÂX vÖebvi†`g\˜ÖS–ºqP>Èg>j¦B–-†Y`«¤rÐƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TI„š×jò,þšþªŒ6¨úøªŽßÑ\à…ITc…J7�±xµÓ	Fú*³üQr«ÖMê•+ŽbÂi¿"‡<D×°³Í�æ»E‡ ¡'·ÒÝMºp`Øt”E¦4Ž=—ØHeÞ0õé:      Ö  —      Ž®ZTR

BASE      x  xÁA  „°Y%<0pþ³ö\Æ,
ŠhnÛ–²ª˜¬�3Ýb¶U E.X�20Œl!Š±tIÂJlË¸2p¸á¹©%ŒpÅŠ²Ð–Š›Ëœ¥nZ®\mcËÅ€¹"­E¶jÎ¬1Ù’ÄU)±¤NmÌFsˆaMJp¬X`À‰™‹µtâbƒd«�k
mÃÉÃmÄÛ ÜdÛÛ Š9jAL·m1˜“…LÝÀm›mŠ‹lª� bÅÜÜ"¦Û¶Íe6˜Ëå–€ €¢9”¬Õ¶¶¥Å„È¡àÜ¶iPWn’D&1®éæh�´ÑF)Š›8×H42tæ\¦kCiår)­ŒA³57´Ú
'„1ÚÐbP&Y³r�UµÙ‘Tr+20tˆ.bè�l‘c�)æ¦e!5¦5È’jH™¹)U¦«1·1š®Ym3EçÂ-²Û¶ËÙ¤ª,Ò±À”³tÛ†µéJ·-Wºm9‘µ¹M—mLu±¹V´±¡é¶h‘‹¡9Ó$�L2š´È(È‚Èt±¬±mN7LæZÖØ&¢ÉX-qNÂ\ÎÅÒd´AJƒÜ¶%@:J§ �N'7W0r¥Q–ÎÒ¹dÀ  6š¤¬Ê"Xe�«,Ú¨²b•EUV8V[.lK–Û’áæÒåªHW…ÛÑÕ–[Ä’å¶d¸¹t¹*ÒUá6EÔ�ÙI‹9ÄiŽ™Ã®š¬\¦¢¦ j.ÌÔ…•[s9µdšB®…6§¹d­IÔ¶‰6™h€™Q’’:µV«f­¦®’ª95¦FªUsa5š0qE¨S¡@2BšÅ\BTÛØŠ!VC­'M˜EáÊT£EÕÖrä–:¤V5·É¦ªÛ6W„0·�mcÆjB›n®6WÎåd6]RhaW´IØZÎMcNÖÎ6‡V£Š2·M…’æŠd™ÛHRÍUâVæ¡•Î•ÎDdSdŠÖ(SÐrÚæ¶Z©nfŠn§SM
ÚTÕT“œÙlIa�4›Gs¶$VH¢¹HXAV£t[•d)Œ$·åt3·¹ÊI”« jÕ´*+'UVNª¬²25¨é´(µds‰¹	�‰Í¥™ks:7�Ìi¥Û,ØLQ[ ÄŠ-1©ÍiinÕŠ(Çf9®AB˜år.–¦­MË5É¤ÊÔÚÜ¶5!4tMk©¸¤0J2Ë1[¹R+ÛtË$×r†mM\�T¸r9¶Ê ¥URÌéšÌ‰n9]�)“•‹%,ËrÉ0·˜–C—Êf(
 3™‘‘Øp+HknÍ˜‹¹Â ’I•3SÒÀµ™RN(3YjXF1g³…ÊÊXºÜÒ`LV+€•æ¶¹b“®•–«ÖÊBsL
ÙVµÅØrAäV–Á*š›Î–Û°ÆLsjl&™ÌtsÌts£ÍÍ…ÙTçÔ©ª:°W¤¹Jk-ÛÖcml›¢Œ-mn[	kQ©èJ]ss#ÙtTÍmªs¦@Áj®-X³I›Îäæ„€`s�u[R’ªŠ®©¥sY
�bkbˆ.�²DP¥¥ØÖ¢­m­€h+çtB66A¨rA±T‚ªl�UÌÅ\•ÎZ"ËmÈZÛhFm €ÍQª(Va«mÓm Æb0fŠ Ä\Š²T ‚( Åš#\!DM8—sNXÐ¬1ƒÒ…!àÌ	�«h‹$ê®ÄBVêrÆRWÂŒX®�’ÉPqs©º‚2š¬„p›ËÁšlšk9§s"3Ã*´dÎ5$¤a€º˜äÌ6]k’PnN]˜¸†9×4m•â6ÄU.[QLŠdB#¢€ˆŠÆæXªâæ"„„-rm†2©H]ºé¶Yº“±Vº"@r@Ë€,+-Æ,ÊbR+kdS�Ù \Öœ“­)Ç P‹pÅd1¶Øca’4XnÛ¶Í™s²m  [PA°µmN7%ÑÙ`[¨ábµ©l4‘¹F65ËÍÚÄ ÁbZZ¦#‚¢EåŠÅŒ²jFQ›PVY¬(ˆ¢,Ê�j�Ê-T*ªj¤Pn*51Ö¨BWsÕš²¬”Z ¡[ÌtÕbQsÖÔÒæÌR¦aP[)›K"	j ‚Í¹¹…Ì¡ájk‘1Í2·)-tPpƒŠVi®ÔÁ¶I	i!ˆÆrIæ’$„0³Ü¬MH 6	‹²×¶Q›³9J È˜.¬šÅ¦È§n:©Y)`©
4u6§RmYZ­Mg“6E±š¦Ä�ÈÑF	“2Èd„8B˜…„HÚr¥ä†N­ÕªY«©«¤jN�©…‘ªÀBÕf«F&N¢u*HF(Æf±$!Êml«¡V†IsÌ‚pe¦Ñ¢jk•sÛØ"çrcŒÐ©hCL‡¦²-›°*‹¶6Ù¶šÚÛVKœÊ6aU+Â­€©¶hšcŠ©l±†K4™(«ÁÈX86b—B£€¦2¨É®’ÁRÊJÙ†6ÙÂ&Œªl¸•ŒÅ·XÃ¥Ð*iÚ€á•-lÂ
hêØÊ6«@†M6¶°	«¬j¶UÖ$¥¬”mhƒ6ÖÀ,pÊ«,Tl±áØ`àhÂ`Âš +k°¶B)ŒkÈØXŒC°±„•B6· ¨t¶¦cÛÆ¨Öd1¬¶¹6©•¸mVk™ªc[ÛØ¶9`È&0Ö˜ædÂ@]XnÂ`lP�Ecd›¶fêÆ¦nÛ–%Û–nº¶m9Q	0Wh ±\“¶j‰Ñª™�+æÉÄt‹hÛL5lÛ‹ÄmÚ\Žµ2klLmmaZ	‘à¬™&C›“`áV[4œ(M$€dnX¬d!"ØXÒr)eÑb .KÁ·9b!w   ¦<AlignableSequences trimStringency="Medium"><Sequence name="addgene-plasmid-220981-sequence-437540" ID="0" sortOrder="1" trimmedRange="0..7679"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
   Ü<?xml version="1.0"?><Features nextValidID="17"><Feature recentID="16" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6615-6719" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="15" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="6788" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="6720-6788" color="#ccffcc" type="standard" translated="1"/><Segment range="6789-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4356-4365" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="11" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6050-6429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5846-6049" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4337" color="#a6acb3" type="standard"/><Segment name="ATG" range="4338-4340" color="#a6acb3" type="standard"/><Segment range="4341-4349" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5670-5845" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5408-5607" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4791-5207" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="4592" consecutiveTranslationNumbering="1" maxRunOn="4646" maxFusedRunOn="4646" detectionMode="exactProteinMatch"><Segment range="4527-4592" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="4646" maxFusedRunOn="4646" detectionMode="exactProteinMatch"><Segment range="4488-4523" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Î» N peptide" directionality="1" translationMW="2701.03" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="4646" maxFusedRunOn="4646" detectionMode="exactProteinMatch"><Segment range="4362-4427" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  Û<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_LambdaN-SD_Frame1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="8:10:4">2025.4.21</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" journal="Unpublished"/>
</References>
</Notes>
  o<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..7126" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..7126" colors="black"/></BottomStrand></StrandColors>   ý7zXZ  æÖ´F !   t/å£àÁÊ^] Ë‡ØÎf‘ƒÊý{3Ôé·Ú(1v%f M*	mj÷)p80çÌ*iÚ	´NY]Qó“�úF7î&ƒÕ!Ò÷¿×|MVmþÖyˆYñÏã°»íæ�¾	êî7?’RZ	Ô�o�óÛ^B
¢�ÑF
‹wïè.×W'Ì1±„æI|˜Îx/àH›Á�Ù¨%_V‹HµœÎ•ùx|ckoRÝ±Äàý(äÈÛÿÐƒ;!ø‚©ÿ”€BÅ<‹ëõu`z´¡Èù<Ÿ=éLCO„¶ÊÅjb”	Ì.8k0Ò½‚æÎxñqB‘H}b†1úîMšDºq°1ž
4‡ü<)=•­f¬b­À�w…ÿ^€â(	I£ŸE+/Å
œ ˆæìVÿo]AÄ‰ÀáE¨v7	Ë"vkJ3nyÑQ/§½Jsi³âTr*;u¬=À+‰„>£û¼x¡a&¬OiÎ;ñSâ!©Rà€Jˆò–&9l¯1¦³èuÞ�ûùC=¬CßÆK9;Åˆ`P6!Ä®õNxå`¯ • wùèù–rI¶Ôƒ›˜—Æ××‘šÁ~‚ û.¥K .�©ô–Íg-¤¤ÜyðfÎ'Nif°H™øóD´{0õäp¹Ž:rÛ¾ÑÏOœÍöÚRED]|é„ØÌÖ±ìí±¿DË‰“]æ{B{©Ù‘àG�pé2Öy¢ŽäÛ9µÇžj¹Ñ]ÅÂZ>Ï<‘7¢ÉY(ÕBPìsÖò3n»â¥ên·€3å+î¾:¥sAa,iŽ†¹Eyª-¯}—ôgoÂ•­§O|Ž“pnŽzamcà6O ¯d~8`‘ü˜¶*9«.kƒ“E¦Ãu_pz’êŸ"�¤^Û®D)0FÞ WDBÂoâºÓ•úSè/�&é [»\jVˆñt†Š�žb¢<‘´XgŠM¬¹–ÏÌg¼®Iô‚&pU»Òp×€xÑ÷:´E›Û¦„’­™Ò8#—|ëCñ:Úå>E”›Ÿ"ëg CÕñ{DÄR:ÉsÕýél´¶.bÛò^3Ö—R-T�CQpˆÑÅWŠâ²UÙPG‘¿žyÿ\‚¦õ
!Êü�0µHUð,\WQ·ŒGøÓ3gYbT™ýF=q9`Òqµì9Ÿ)ôñàòøfvåõ3Iã'¾m®ì€¹×÷ÚÛnÏ­ŽÅ]Ï�¦ÿªU7üÆ)Bp‹-Á"ÜX÷ÿ•�5O+Ðù�T–Ón™”ÖØ;O\„ùdm��Ü�j,v=Ié1eh÷QÌçú(ŽVÅ‘Ô8ÉÖBö_´ýj1°t†?íKÀ-5–¦Ž°
OæÃÊ	¨÷B‘1íBí'°¸öJù¨,»ùˆË®zs}CLSÏ+Lú²›\•ƒÌÒGÔ§ÑµŸ;´ûdrZ'êûuëî/ «z�%;È�0=¢Cü×UG®B„>JÜ%ºÍïæ¸¹öZg>G�‚5c%™{à:@ÔV†“‡Qæ[ªÉ—•Â©Aì™hŠÄñCÔ
‹å�ÚuhñÇˆw~ ”€è¥Y$åëÿ@ëJ¡}KV”É’5ººÊŸ¬•!b«3ç«*IzîæWK�U“¬¶ˆ¿x3~Éª¤&t¡0Ñi:òê�ßFme‘×uåkîÛyf¢[�5¾À]|8ùë	£úèQôYvÜLaIë˜@‡ù-3ð×pô‰!«¸•@Ntïk•àÇŽMŸwõk ìF}¾P#f=„©ô’
‡“k�Þ·´bO:5è7u‰P“†›p¨~=º™„YPÝ¢qx(õ¢®`M„n<wnzuE^Û+ÌÖË\L­N»xœ–½tfF eôôo¨ƒEŒ‘ÔqF”—"³h§½L`P²ÖË xY¾=a2ypnÒ�fYsZî“­Xš·läæ'‡å3ÀjPá›Vq÷Ü<O‚d¨ÐSr#¯¾e”+ÜŸ›6ÿ¢ýÕõRžï\°
 ä%ˆŸftëxdB²ÅBÖª³7±	�µàSpï©àv_Ô¶pæ9W¥9ìiÍüØïãç-U�ÂéFÌ«	ÃH‡°Ó”ðU‚þ6/=dQ<zNÆƒzT«&k0Éçï†�G?os7«$[_ºŒÜ†ÉÉ?úß+ºrq¾«N¬¥\àb²,Ò'¥Æ#¤ õGÇð[y4ÐJ»¬ @P<I Ø­[rãËêNÅÒ¾í{sº|‚å­5BÍñùtH�XõÖ‰õS»NRî?´VÔÅ
ê~ÜAàäu¹}XŸ‚?¿ Ä¿Ga¶£o�/)VLF^’ª�æ†Ne½• hœÿ.àõ.Á“,¦×šÖ	sj÷±Í>Ö†O•/@ãY.ýZÈ´ïçRÐJý3íš÷$SD|[Å]ÉBšD8œO~Ï/LÙ;êyWÈÚD6D¥ÝòµõtÃ¥š4FÓúá†%?|h�ª@ã]zP/_?»Ìê„Oüãºª~Æòµ�$Ò1pZ»ÑIËkÐÙQ“œaòÝ mŠ¦…�ÇïÂóâèP(‡H;7Q²«Šõ]ì"Ä1%)çˆÕ'Ê·zhKW…-Þõ	X_Sˆ§ßSø° á$Ìfo„„É@6v§  ×eöy<0¨òÑ,=Q¯ïfîqùÐÀ×#1[C*f0­Ñ§`NN@Û,"%ñœ¼ìzq%¹�lÄŒ{þúy÷{%LÑÉ]wöËÜç�Áe‚äêôÑN·ƒá|}ŒÖäÙz?YÍ¢eˆjSz{wõ‘ä–W±[²Îð_ðTÑ‹3oÑl}ŸZ&ýÞ¯öŠ¼—�Q•/‘�³�bï¤öTSÈ €ŽÚY°É(¹Ø›á³_š$³só¿+ÎZ[Á�3Eñ‰n‘ìá¡º0p¯Z½Êˆ9ët*;Yp²}W·«'ÛåúD@êA)´R«‹tJìœ‰@…ßIm˜Ä¿n�š×÷*Ç¡#n–DûA ¹-~$ó�;ÁR l1.Á=™)SGÔ¼ãƒ8…Rf¸1r•Ä+8ÐŽ•†‰¶ a ÇA›¤ÃÓc×Q2¨¶Ö>(o/u³89Û«$9Ûk‹'fEZ;ö‰ísðSp¹ »‡ùia¶;#îd…'I=td„­ [±¢ß¸poèÚIž§‰„Ú{WëYnÍÉÿ�ºv†W1(ÿ
sÊÛËØÌ%Ð1‚ò¥	×=Ogz•HDt&Ø¹-fŽy&š7yd]EŸÖW†:ØÍŸ—µi`O‡Ü8Y&fö§é0@e?E³o�xô�,næ$ñ
€QÈ$Ìªe††¡TTUCÁKý„t«9eIt«½¢–žåÿ¨ø¹¯?‰³sµ+€¬æ¼œØYa»º$"Ç_êP_BÇ3)†àŽtÙ$ÏýìXÖ 	ÊÓhÃ&†’’¤dŒŸ ŠKU½
Q@çŒëüÞî8ãâïq›ë…©ÂYLÜ¹E§8x/?#®œS0©	›á�ö§Ö u™
ì—Ÿ_øáwè�õkû½_;Ï—Ìx�ÿ¤„4­éd9Ísw»ú%ý€
Óã2+RÖ2h '}ƒ)°|ÇÜÙ�‡aã Æ–‘÷é“¤�ïR�O#®�³-Æ&Û{)ÿ8=8~~'a0Éfðöý€&3;."în¸1Aç�¯UZŽÃ[>®6«³�áÃ€ÞM÷Ã*Óˆu¿¶üáZu:žùq%üº²Ïc�7®˜¦b¯¯@º°D¬Ñ^ìN(XãòŠ«*3²ÜÌæ‰ýùÒÊŸ@ªËŒWûO8gáE
û(¢ñ~‡ªo¨þ «¶Š!É–¨ÇäªMÙ`ZEü¼w!.Î²K†K0    ¡&Ÿ'Û±u úËƒ �îñ±Ägû    YZ   -<AlignableSequences trimStringency="Medium"/>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  &<?xml version="1.0"?><Features nextValidID="18"><Feature recentID="0" name="BC2 tag" directionality="1" translationMW="1422.57" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5042-5077" color="#ce98b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;nanobody epitope tag corresponding to amino acids 16-27 of human&amp;nbsp;Î²-catenin (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25595278&quot;&gt;Traenkle et al., 2015&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="PDRKAAVSHWQQ"/></Q></Feature><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.71" type="CDS" allowSegmentOverlaps="0" cleavageArrows="5146" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="5081-5146" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="DYKDHDGDYKDHDIDYKDDDDK"/></Q></Feature><Feature recentID="2" name="gag (truncated)" directionality="2" type="CDS" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5347-5763" color="#993366" type="standard"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated Moloney murine leukemia virus (MMLV)&amp;nbsp;&lt;i&gt;gag&lt;/i&gt; gene lacking the start codon&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="MMLV Î¨" type="misc_feature" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5964-6163" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;packaging signal of Moloney murine leukemia virus (MMLV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="5' LTR (truncated)" type="LTR" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6226-6401" color="#ffe4c4" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;truncated&amp;nbsp;long terminal repeat from Moloney murine sarcoma virus&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="IRES2" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3763-4336" color="#a6acb3" type="standard"/><Segment name="ATG" range="4337-4339" color="#a6acb3" type="standard"/><Segment range="4340-4348" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="PGK promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2451-2950" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mouse phosphoglycerate kinase 1 promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 ori" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1519-1654" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1505-1834" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="2" type="promoter" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6402-6604" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV enhancer" type="enhancer" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6605-6984" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4355-4360" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="12" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="624-1212" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="NeoR/KanR" directionality="1" translationMW="29047.90" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2963-3757" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF*"/></Q></Feature><Feature recentID="14" name="AmpR" directionality="1" translationMW="31515.28" type="CDS" allowSegmentOverlaps="0" cleavageArrows="7343" consecutiveTranslationNumbering="1" hitsStopCodon="1" detectionMode="exactProteinMatch"><Segment name="signal sequence" range="7275-7343" color="#ccffcc" type="standard" translated="1"/><Segment range="7344-453" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to ampicillin, carbenicillin, and related antibiotics&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;Î²-lactamase&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MSIQHFRVALIPFFAAFCLPVFA,HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW*"/></Q></Feature><Feature recentID="15" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7170-7274" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="16" name="Kozak sequence" type="regulatory" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4361-4363" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;vertebrate consensus sequence for strong initiation of translation (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3313277&quot;&gt;Kozak, 1987&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="regulatory_class"><V predef="other"/></Q></Feature><Feature recentID="17" name="Î» N peptide" directionality="1" translationMW="149.21" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="5155" maxFusedRunOn="5155" detectionMode="exactProteinMatch"><Segment range="4361-4363" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;N-terminal RNA-binding domain from the Î» bacteriophage antiterminator protein N (&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot; title=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14770003&quot;&gt;Baron-Benhamou et al., 2004&lt;/a&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="protein_id"><V text="&lt;html&gt;&lt;body&gt;&lt;br&gt;&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="M"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  
<Notes>
<UUID>da52efae-514d-466e-94c5-17c0d47d1402</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>ORFtag_TetR-SD_Frame3</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Description>ORFtag viral retroviral vector containing a constitutively active promoter and a LambdaN tag followed by a splice donor sequence in Frame1.</Description>
<Created UTC="4:0:0">2025.4.14</Created>
<LastModified UTC="20:59:39">2026.3.6</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>unspecified</TransformedInto>
<References>
<Reference journal="Unpublished" title="Proteome-scale tagging and functional screening in mammalian cells by ORFtag" type="Journal Article" journalName="Unpublished"/>
</References>
</Notes>
  Y     K         
?????                                                                                                       ÿ d      DO  d              E              ÿÿÿÿYô? P                                                                                                                                                             /<StrandColors><TopStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..6478" colors="black"/><ColorRange range="6479..6507" colors="red"/><ColorRange range="6508..6536" colors="purple"/><ColorRange range="6537..6627" colors="black"/><ColorRange range="6628..6667" colors="green"/><ColorRange range="6668..7681" colors="black"/></TopStrand><BottomStrand><ColorRange range="0..3755" colors="black"/><ColorRange range="3756..3781" colors="light blue"/><ColorRange range="3782..4359" colors="black"/><ColorRange range="4360..4386" colors="light blue"/><ColorRange range="4387..5008" colors="purple"/><ColorRange range="5009..5145" colors="black"/><ColorRange range="5146..5147" colors="light blue"/><ColorRange range="5148..6478" colors="black"/><ColorRange range="6479..6507" colors="red"/><ColorRange range="6508..6536" colors="purple"/><ColorRange range="6537..6627" colors="black"/><ColorRange range="6628..6667" colors="green"/><ColorRange range="6668..7681" colors="black"/></BottomStrand></StrandColors>   3<?xml version="1.0"?><EnzymeVisibilities vals=""/>
   )<?xml version="1.0"?><CustomEnzymeSets/>
